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GENERAL ABSTRACT 
The current testing of leptospiral bacterins licensed by the United 
States Department of Agriculture requires a hamster potency assay. The 
hamster potency assay involves vaccinating hamsters with a specified 
dilution of the bacterin. Two weeks post- vaccination, hamsters are 
challenged with virulent leptospires and the percent survival is 
determined. A bacterin is considered satisfactory if 80% or more 
vaccinated hamsters survive a virulent challenge. There is a need for a 
rapid, sensitive, and reliable alternate method that could be used in the 
routine testing of leptospiral bacterins. The large number of hamsters 
required for the manufacture and testing of these biologicals is expensive, 
and increasing concern for animal welfare and human hea~th T.akes in vitro 
assays for measuring vaccine potency desirable. An enzyme-linked 
immunosorbent assay (ELISA) would be simple, safe, easily automated, 
inexpensive, and suitable for potency testing of large numbers of product 
serials. The objective of this research was to d e velop an ELISA-based 
detection system for measuring the relative potenc y o f leptospiral 
bacterins as an alternative to the hamster potency assay . 
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GENERAL INTRODUCTION 
The National Veterinary Services Laboratories (NVSL) are responsible 
for the laboratory support with regard to licensing of animal vaccines of 
viral and bacterial origin as well as veterinary diagnostic kits. 
of vaccines and bacterins includes efficacy, potency, and safety. 
procedures are well established for veterinary biologicals (1). 
Testing 
These 
The current ~esting of leptospiral bacterins Jicensed by the United 
States Department of Agriculture requires a hamster potency assay (1). The 
hamster potency assay involves vaccinating hamsters with a specified 
dilution of the bacterin. Two weeks post-vaccination, hamsters are 
challenged with virulent leptospires and the percent survival is 
determined. There is a need to replace the in vivo assay with a rapid, 
sensitive, and reliable alternate in vitro method that could be used in the 
routine testing of leptospiral biologicals. The large number of hamsters 
required for the manufacture and testing of these biologicals is expensive, 
and increasing concern for animal welfare and human health makes in vitro 
assays for measuring vaccine potency desirable. An ELISA would be simple, 
safe, easily automated, inexpensive, and suitable for potency testing of 
large numbers of product serials. The objective of this study was to 
develop an in vitro assay for measuring the relative potency of leptospiral 
bacterins as an alternative to the current hamster potency assay. 
Explanation of thesis format 
Two papers are included in this thesis. The manuscript, "Assay for 
measuring the relative potency of leptospiral bacterins containing serovar 
pomona" by K. W. Ruby, M.A. Cardella, and w. u. Knudtson, has been accepted 
by Biologicals. The research was conduc ted at the NVSL in Ames . As 
principal investigator for the project, I was responsible for planning, 
coordination of activities, labo ratory analysis, performing the work, 
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presentation and reporting of results. Additional work not included in the 
manuscript is also included in the Appendices. 
A second manuscript is also included with this thesis entitled 
"Development of an in vitro assay for measuring the relative potency of 
leptospiral bacterins containing serovar canicola" by K. W. Ruby, c. L. 
Egemo, and D. M. Walden. This manuscript will be submitted to Biologicals 
for publication consideration. The work presented in this thesis on the 
development of the L. canicola in vitro assay is the first publication of 
this work for this serovar. Both manuscripts are in the journal format for 
Biologicals. 
The papers are preceded by a general introduction and a literature 
review. There are four appendices following the first paper that include 
additional data that was not included in the original manuscript. A 
general summary and references cited in the literature review, appendices, 
and general summary follow the second paper. 
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LITERATURE REVIEW 
Leptospiral Taxonomy 
Leptospires are classified in the order of Spirochetales and in the 
family of Leptospiracea. Genus members include Leptospira and Letponema. 
The genus Leptospira is divided into two species: L . biflexa which are 
saprophytic and non-pathogenic, and L. interrogans which are pathogenic. 
The basic taxon is the serovar, with serovars having common surface 
antigens grouped into serogroupR . Currently ~here are over 180 known 
pathogenic serovars assigned to 20 serogroups on the basis of cross-
reacting antigens (2). 
The various pathogenic leptospires are not readily distinguishable on 
the basis of morphological, biochemical, and cultural characteristics. 
They do, however, have distinct antigenic properties that can be 
demonstrated by a serological test called the microagglutination test (MAT) 
(3). These properties are important for serological diagnosis and provide 
the basis for classification . 
Leptospiral Morphology and Structure 
Leptospires are flexible, helical cells with ~imensions of 0.1 µm in 
width by 5-30 µm in length. Leptospires are spirochetes with a coiled 
structure and an intracellular or periplasmic flagellum that is proton-
driven. In the periplasmic space, the two flagella (axial filaments) are 
attached through an insertion pore at each end of the organism and is 
covered by outer protein sheath (2,4-6). These filaments are responsible 
for motility of the organism. The ends of the organism are hooked. When 
the organism moves there is a bidirectional, serpentine-like motion. When 
the organism moves forward, the anterior hook disappears and the trailing 
end retains the shape of a hook. 
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The three major components of the leptospiral cell are the outer 
membrane, cytoplasm, and axial filament (5-7). The structure and 
composition of the outer membrane of Leptospira resembles the outer 
membrane of other gram-negative bacteria (5,7,8). I-eptospira, however, 
appear to have 46% protein, 27% carbohydrate, and 22% lipid as the major 
macromolecules present in the outer membrane (8-10). Like gram-negative 
bacteria, these substances are components of lipoproteins, phospholipids, 
and lipopolysaccharide (LPS) in leptospiral outer membranes (5,7-10). It 
is common among Leptospira to find phosphatidylethanolamine composed mainly 
of hexa- and octadecenoic acid (5). Leptospiral LPS differs from the 
classical LPS by its lack of 2-keto-3-deoxy-octulosonic acid (KOO) and L-
glycero- D-manno-heptose (5,11-15). Sugars such as arabinose, rhamnose, 
xylose, galactose, mannose, eryhtrose, fucose, and glucose have been 
described as components of the O antigen in Leptospira (5,11,12,16). 
Leptospira have a gram negative outer membrane composed of an LPS-
like substance. Lipid A appears to be absent in the outer membrane 
(5,12,13,16,17). These differences may account for a number of leptospiral 
LPS characteristics including low cytotoxicity, pyrogenicity, mouse 
lethality, and mitogenicity (18-21). 
The leptospiral axial filament is composed of a sheath and an inner 
core (10,22,23). At least six proteins have been identified as part of the 
axial filament (22) while other reports indicate that there are four axial-
filament proteins (24). A doublet composed of a 33-34 kilodalton (kDa) 
band and a 37 kDa band were the most prominent proteins in polyacrylamide 
gels (24). Leptospiral axial filaments have protein electrophoretic 
profiles similar to those of treponemes (5,24). The cytoplasmic cylinder 
has an internal cell wall structure that is composed of a peptidogl ycan 
layer under which the cytoplasmic membrane is present. These structures 
maintain the integrity of the organism (5). 
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Leptospiral Zoonosis 
Leptospires occur naturally in a wide variety of feral and domestic 
mammals. In natural hosts, the spirochetes colonize the kidneys and are 
shed in the urine. Humans are accidental hosts, with most infections 
related to occupational or recreational activities involving either direct 
contact with animal urine (e.g., fish workers in rat-infested surroundings, 
abattoir workers, miners, or sewer cleaners) or contact with water and soil 
contaminated with animal urine (e.g., rice fields, cane fields, ponds and 
streams, etc). 
Leptospires have very definitive maintenance host specificity. The 
organism is usually more parasitic than pathogenic and is sned in the 
urine. Maintenance hosts for Leptospira serovars are the rat 
(Icterohaemorrhagiae), dogs (Canicola), raccoon (Grippotyphosa), cattle and 
swine (Pomona), cattle and sheep (Hardjo), and sheep, swine and the hedge 
hog (Bratislava). A study performed at the University of Minnesota 
Veterinary Diagnostic Laboratory (25) indicated that the incidence of 
Leptospira serovars in descending order was as follows: Cattle (pomona > 
icterohaemorrhagiae > hardjo > grippotyphosa > canicola), swine 
(icterohaemorrhagiae > pomona > grippotyposa > canicola > hardjo), horses 
(icterohaemorrhagiae > pomona > grippotyphosa > canicola), and dogs 
(icterohaemorrhagiae > pomona > canicola > grippotyphosa). Leptospira 
pomona is the least adapted Ger0vn~. With thP. exception of the Minnesota 
study, L. hardjo has rarely been isolated from swine. Humans generally 
become infected with serovars Icterohaemorrhagiae, Pomona, and 
Grippotypohsa. 
Leptospiral Pathogenesis 
Leptospirosis is an acute, febrile, septicemic disease attributable 
to any one of the large number of serologically distinct members of 
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L. interrogans. The routes of infection are usually the eye, broken skin, 
mucous membranes, and oral ingestion. Transmissio n of disease may be via 
urine of an infected animal or semen/venereal. Transmission may also be 
horizontal. Known virulence factors of leptospires include motility, 
hemolysin and cytotoxin production, and factors contribut ing to the e vasion 
of the host immune responsQ (26 - 33 ) . The p~thogene~is o f t~e disease 
following penetration of mucous membranes by actively motile leptospires 
begins with a bacteremia 7-10 days after infection. The organisms colonize 
the liver, spleen and kidneys. About 7 days after the start of the 
bacteremia, specific antibody titers to leptospiral antigens begin to 
increase and the organism disappears from the tissues and circulation, 
except in the kidneys, reproductive tract and some areas such as the 
central nervous system and the eye. 
Clinical Manifestations 
The clinical manifestations of leptospirosis are variable and depend 
o n whether the inf~cted animal is a definitive host or an incidental host. 
In general , symptoms of leptospirosis range from inapparent infections to 
flu-like illnesses to "aseptic " meningitis , and, less frequently, to an 
icteric-hemorrhagic form with severe hepatic and renal involvement . 
Leptospiral infections in a definitive host may r esult in a low sero logical 
response , chronic reproductive disease, long-term shedding , and a high 
frequency o f intra-herd transmissions. Leptospiral infections in an 
incidental host may result in acute, severe disease, lack of detectable 
shedding, and a high serological response. All ages and sexes of 
incidental host may be affected with a low frequency of intra-herd 
transmissions. The acute phase of the disease p r esents with septicemia, 
pyrexia, anorexia , acute hemolytic anemia, hemoglobinuria, jaundice, and 
agalactia . The chronic phase may present with prolonged convalescence, 
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kidney and liver damage, and abortion and stillbirths. one of the most 
common signs of leptospirosis in animals is reproductive failure 
(abortions, stillbirths, and infertility) (34-37). In cattle infected with 
leptospires, calves borne to infected cows will be chronically infected 
with L. hardjo but are asymptomatic. In swine, L. bratislava produces 
reproductive disease. In horses, abortions are due to L. pomona 
(especially in vaccinated horses). In dogs, severe pulmonary hemorrhage is 
due to serovars icterohaemorrhagiae and canicola. 
Leptospiral Immunity 
Leptospirosis in animals may be controlled by vaccination. In 
general, immunity is measured by a rapid and strong antibody 
(agglutinating) response. Following an active infection, the duration of 
immunity is lifelong and is serovar-specific. Although cell-mediated 
immune responses are involved, immunity to leptospirosis is primarily 
antibody mediated (38-49). Current L. interrogans vaccines composed of 
heat-killed or chemically inactivated bacteria can protect animals against 
clinical signs of leptospiral infections (25,38,41,43,50,51). 
Leptospiral Antigens 
The primary targets for immunoglobulin-mediated killing of 
L. interrogans are located in the outer membrane (4,6,7,40,52,53). 
Leptospiral antigens include a lipopolysaccharide-like substance (LLS), 
outer membrane proteins, and flayellar proteins. To date, LLS is the only 
agglutinating and opsonic antigen to be identified (14,16,18-21,54-56). 
Recent studies indicate that immunization with LLS can confer protection 
from infection in hamsters (55-57). 
The outer membrane of L. interrogans has been shown to contain a 
glycolipid antigen (5,15,57). High-titer agglutinating antiserum can be 
/ 
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obtained after immunization with purified leptospiral LLS 
(16,18,38,39,44,56). Leptospiral LLS, like gram-negative LPS, is thought to 
be important in evading the induction of the complement cascade 
(21,29,38,46-49). Leptospiral LLS is a glycolipid and is active in the 
limulus ameobocyte lysate assay although it lacks 2-keto-3-deoxyoctulosonic 
acid and the endotoxic properties of gram-negative LPS such as 
pyrogenicity, toxicity, mitogenicity, activation of the fibrinolytic and 
complement systems, adjuvancicity , and indu~tion of interferon production 
(12,16,17,19,21,48,49,56). 
The outer envelope of L. interrogans contains carbohydrates, lipids, 
and at least 9 different proteins (58). The outer envelope contains 
several potent immunogens; hamsters (41,50,59), dogs (41,51), guinea pigs 
(42), and cattle (43,38) have been vaccinated with outer envelope-enriched 
preparations and were shown to have a high antibody response based on the 
microagglutination test. These vaccinations were successful in preventing 
death and, frequently, the renal carrier state. There is very little 
information available about the ability of the outer envelope proteins to 
elicit a protective immune response, or about their function (31,58). 
Zuerner et al (9) have rec~ntly ext~a~ted a m~jor ~~llu!ar ~rotein from the 
outer membrane. The major cellular protein was identified as a 31 kDa 
hydrophobic protein located in the outer membrane and is exposed on the 
surface of the cell. Sera from infected animals reacted with this 
immunogen on western blots. This is the first documentation of a major 
outer membrane protein that is immunogenic . 
Leptospiral Monoclonal Antibodies 
Most monoclonal antibodies which recognize antigens of L. interrogans 
are directed against LPS (54,55,60,61). This may be due to the fact that 
surface proteins from L. interrogans and other bacteria are closely 
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associated with, and difficult to separate from, immunodominant LPS 
(11,12,62,63) . There have been few reports of the development of 
monoclonal antibodies directed to surface proteins 0 f L. interrogans which 
provide passive protectio n against a virulent challenge (64, 65). 
Leptospiral ELISAs 
Enzyme-linked immunosorbent assays (ELISA) have been used in many 
laboratories for diagnosis of l ept ospirosis in humans and other 
animals (66-76). Studies have shown that the ELISA is more sensitive than 
the MAT for detection of antibodies against L . interrogans (73-75,77) . 
Both genus-specific and serogroup-specif ic antigens have been detected in 
ELISA. Genus-specific antigens were prepared using detergents (69). 
Serogroup-specific antigens have been prepared using phenol- water 
extract i on ( 70) and sucrose gradient purification of the outer envelope 
(67). Crude antigen preparations have been prepared by sonicat i on (65,75) 
and heating of who le cells ( 70). In 1990, Champagne et al (7 8 ) reported o n 
the development of a sandwich ELISA system for detection a nd 
characterization of leptospiral antigen s in c linica l specimens . There are 
no reports of an ELISA-based detection syst em for measuring the relative 
potency of l eptospiral bacterins. 
Ob j ectives and Rationale for Study 
The objectives of this r esearch were to develop in vit r o assays for 
measuring the relative potency of l ept ospiral bacterins containing serovars 
pomona and canicola as an alternative to the current hamster potency test. 
These assays are sandwich ELISAs utilizing polyclonal hyperimmune rabbit 
sera to capture ant igen i n bacterins. Monoclonal antibodies are used to 
detect antige n in the c aptured bacterins, followed by an anti-mouse 
horseradish peroxidase-labeled antibody and subsequent addition of color 
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substrate. 
Although LPS is the most protective leptospiral irrununogen, I chose to 
use a "shot-gun" approach to obtain irrunune spleen cells with antigenic 
specificity for proteins as well as LPS. Because Triton X-100 is a non-
ionic detergent and will solubil ize outer membrane proteins (79), a Triton 
X-100 extract of serovars pomona type kennewicki and the NVSL challenge 
strain of portlandvere was used to irrununize BALB/c mice. These serovars 
are the type strains used in leptospiral bacterins manufactured in the 
United States. The results of these studies will have a significant impact 
on the veterinary biologics industry as well as the NVSL with respect to 
testing leptospiral vaccines . In addition to leptospiral vaccine tes ting, 
the ELISA procedures developed in this study have the potential for use in 
diagnostic applications such as identification of Leptospira in semen and 
other biological samples. 
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PAPER I. ASSAY FOR MEASURING THE RELATIVE POTENCY OF 
LEPTOSPIRAL BACTERI NS CONTAINING SEROVAR POMONA 
K. W. Ruby1, M. A. Cardella', and W. U. Knudtson2 
1Nati.onal Veterinary Servic0~ Labo~atorie~, Veterinary ~erv~~es, Animal and 
Plant Health Inspection Service, U.S., Department of Agriculture, Ames , 
Iowa 50010 
2Sanofi Animal Health, I nc . , Lenexa, Kansas 66215 
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ABSTRACT 
An enzyme-linked immunosorbent assay (ELISA) was developed for the 
quantitation of leptospiral antigen in bacterins containing Leptospira 
interrogans serovar pomona type kennewicki. A monoclonal antibody (MAb), 
2D7, which is directed against a surface antigen on whole cells of 
L. interrogans serovar pomona type kennewicki, was used in the assay. The 
capture of antigen in bacterins by a polyclonal antiserum was followed by 
the addition of the 2D7 ascites fluid, an anti-mouse immunoglobulin 
conjugate, and substrate. Vaccines evaluated with this system included 
preparations containing type kennewicki antigen (homologous) and those not 
containing type kennewicki antigen (heterologous). Heterologous bacterins 
gave optical density (OD) values comparable to those of blank wells. 
Homologous bacterins yielded OD values equal to or greater than those of 
the National Veterinary Services Laboratories (NVSL) reference pomona 
bacterin. The relative potencies (RP) of 84 licensed commercial L. pomona 
bacterin serials were evaluated against the NVSL reference pomona bacterin 
using the NVSL Relative Potency computer program. Random samples of 1-, 
2-, 3-, and 5-ml dose products were selected f or evaluation with this 
system and had an RP of 1 . 0 or greater. All products tested passed the 
hamster potency assay required for leptospiral bacterins. This ELISA 
system enables detection of antigen in bacterins containing L. interrogans 
serovar pomona type kennewicki and demonstrates the potential for in vitro 
testing of leptospiral bacterins. 
13 
INTRODUCTION 
Leptospirosis is a disease of domestic animals. Leptospira 
interrogans serovar pomona causes leptospirosis in cattle and swine with 
the cardinal sign of the disease being abortion. At the present time, the 
best preventive measure is vaccination with bacterins which, in many 
countries, contain chemically inactivated whole-cell leptospires. 
Leptospires are classified into serovars based on agglutination 
reactions with rabbit antisera . The basic taxon for Leptospira is the 
serovar, each having one or more strains. Serovars having common surface 
antigens are grouped into serogroups. 
The current testing of leptospiral bacterins licensed by the United 
States Department of Agriculture requires a hamster potency assay (1). The 
hamster potency assay involves vaccinating hamsters with a specified 
dilution of the bacterin. Two weeks post-vaccination, hamsters are 
challenged with virulent leptospires and the percent survival is 
determined. The large number of hamsters required for the testing of these 
products is expensive, and increasing concern for animal welfare and human 
health makes in vitro assay s fo~ ~easuring ~~ccine potency desirable. 
Monoclonal antibodies (MAbs) have been prod uced by several 
laboratories in an attempt to determine the nature of those leptospiral 
antigens that stimulate production of protective antibodies (2-14). 
Leptospira interrogans serovar pomona type kennewicki is commonly used for 
preparing most serogroup Pomona bacterins in the United States. Monoclonal 
antibodies to antigens of this serovar would be useful for in vitro assays 
for quantifying antigen in pomona-containing bacterins. We chose to use a 
Triton X-100 extract of serovar pomona type kennewicki for the production 
of the 207 MAb for use in an ELISA-based detection system. This report 
describes an in vitro assay for use as an alternative to the hamster 
potency assay. 
Bacterial Strains 
14 
MATERIALS AND METHODS 
MatecialG 
Leptospira interrogans organisms used in this study were obtained 
from the National Veterinary Services Laboratories (NVSL) collection. 
Strains virulent f or hamsters included L. pomona 11000 (MLS), L . hardjo 
11601 (SC1769), L . grippotyphosa 11808 (Oregon shrew) , L . canicola 11203 
(Moulton), and L . icterohaemorrhagiae 114 03 (CFl). Leptospira bra tislav a 
2a and L. bratislava jez were also used. Serovars within the Serogroup 
Pomona used i n this study included kunming KS, mozdok 5621, tropica CZ 
299U, pomona pomona , tsarat sovo B-52 , and proechymis LT 796, as well as the 
type strain kennewicki 1026 of serovar pomona. Unless indicated, all 
organisms were heat inactivated by incubation in a 5~ C water bath f or 30 
minutes. One-hundred microliter aliquots of the heat-inactivated cultures 
were used to inoculate medium to establish cell death. 
Bacterins 
Bacterins used in the antigen extinction studies and t ested by the 
ELISA included licensed commercial adjuvanted bacterins (monovalent a nd 
multivalent). The NVSL reference L. pomona bacterin was also e valuated. 
Animals 
New Zealand white rabbits (Harlan-Sprague-Dawley, Inc. , Indianapolis, 
IN) were used to prepare polyclonal, serovar -specific antisera. 
Fifteen- to twenty-g male BALB/c mice (Harlan- Sprague-Dawley Inc ., 
Indianapolis, IN) were used f or MAb production. Antigen extinction studies 
were perfor med in 40- to 50-g male golden Syrian hamsters (Sasco , Inc., 
Omaha , NE). 
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Antisera Production 
A hamster virulent culture of L. pomona was used to inoculate each of 
two tubes (l ml each) of s emi-solid P80- BA media. The tubes were then 
incubated at 37° c f o r 21 days . Sterility of the culture was determined by 
inoculating two 5% bovine blood agar plates , two tubes of fluid 
thioglycolate, and t wo tubes o f trypticase soy broth with 200 µl each of 
the culture. One set of each inoculated media was incubated at room 
temperature (27° C\ and one set at 37° C for seven days. 
Two rabbits were inoculated with 1.0, 2.0, 4.0 , and 5.0 ml of the 
P80-BA semi-solid culture. All inoculations were given intravenously in 
the marginal ear vein. The fir st three inoculations were given at 5 day 
interval s and the final inoculation was given at 7 day intervals. All 
inocula consisted of viable leptospires. After the final inoculation, the 
rabbits were obser ved for 10 days. On the tenth day , blood was obt ained by 
cardiac puncture and the serum harvested by centrifugation at 3,000 x g 
for 15 min. The serum was t hen filte red with a 0.22 µ filter (Millipore 
Corp., Bedford MA) and stored at -70° C in 1 ml aliquots . 
ELISA Reagents 
Ho rseradis h peroxidase (HRP) conjugated goat anti-mouse I gA (o ) 
conjugate and 3, 3' , 5 , 5'-tetramethylbenzidine (TMB) (Kirkegaard- Perry 
Laboratories, Inc., Gaithersburg , MD) were used as the antibody conjugate 
and substrate respectively . Polyvinyl alcohol (PVA) was obtained from 
Aldrich Chemical Co., Inc., Milwaukee , WI . Polyclona l rabbit anti-pomona 
serum was produced at the NVSL. Immulon-2 microtitration plates were 
obtained fr om Dynatech Laboratories, Inc., Alexandria , VA. 
The capture antisera was diluted in coating buffer (0.05 M carbonate 
buffer , pH 9.6) containing 1.59 g Na2C03 and 2 . 93 g NaHC03 per liter of 
distilled water. The pH was adjusted to 9 . 6. This solution was stored at 
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4° c for no longer than 1 week. The antigen (bacterin) diluent was 
phosphate buffered saline (PBS) (0.15 M, pH 7.2) and contained 8.0 g NaCl, 
0.2 g KCl, 1.15 g Na2HP04 , and 0.2 g KH2P04 per liter of distilled water. 
The diluent was adjusted to pH 7.2 and filter sterilized (0.22 µm). The 
blocking solution consisted of a 1% solution o f PVA (88% hydrolyzed, MW 
10,000) in antigen diluent. Antibodies were diluted in blocking solution 
supplemented with 1% no rmal rabbit serum . 
Methods 
Antigen Extractio n 
Leptospira interrogans organisms were grown in 1 L P80 liquid media 
(10) f o r 7 days at 30° C. Cultures of L. pomona type kennewicki harvested 
after 7 days inc ubation contained approximately 1 x 106 leptospires/ml. 
The o r ganisms were harvested by centrifugatio n (1 2 , 000 X g for 30 minutes) 
and were washed three times in P~S (pH 7.2). Pellets were resuspended in 6 
ml of a tris-tricine, 5 mM ethylenediaminetetraacetic acid (EDTA) so l ution 
(pH 8.6) containing 0.01% Triton X-100 (Sigma Chemical Co ., St. Louis, MO). 
Suspensions were incubated overnight on a platform rocker at room 
temperature and then centrifuged as described above. Supernatants , which 
contained the outer envelope membranes (2, 16,17), were filter sterilized 
(0.22 µm) and stored at 4° C. These super natants were used to immunize 
BALB/c mice for the production of the MAb . 
Monoclonal Antibody CMAbl Production 
BALB / c mice were injected intraperitoneal l y (ip) with nonadjuvanted 
Triton X-100 extract of serovar pomona type kennewicki containing 
approximately 50 µg of protein. A booster injection containing 50 µg of 
p rotein was given intravenously 3 weeks later. The MAb (207) was produced 
by the method of Van Deusen and Whetstone (28,29) using the Triton X-100 
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extract of L. interrogans serovar pomona type kennewicki. Selection of 
positive clones was based on a) high ELISA optical density (OD) values with 
the homologous antigen and no cross reactivity with heterologous antigens, 
and b) western blot analysis. The selected clone, designated 2D7, was used 
to prepare ascites fluid. The ascites flu i d was screened by ELISA, western 
blot analysis, and passive protection studies in hamsters. The a ntibody 
isotype of the 2D7 MAb was determined to be IgA using a Mouse Typer Sub-
I sotype Kit (Bio- Rad Laboratories, Richmond, CA) . The antibody 
concentration of the ascites fluid was determined using a radial 
immunodiffusion kit (Calbiochem, San Diego, CA) . 
Microscopic Agglutination Test (MAT) 
The MAT was performed according to standard protocols (17). Briefly, 
serial 2-fold dilutions (beginning with 1:20) of the 2D7 MAb were prepared 
and incubated with viable cultures (with nephalometer readings of 20-30) of 
serovars icterohaemorrhagiae, grippotyphosa, canicola, bratislava 2a, and 
pomona type kennewicki. In addition to type kennewicki of serovar pomona, 
the following serovars of the Serogroup Pomona also served as antigen: 
kunming KS, mozdok 5621, tropica CZ 299U, pomona pomona, tsaratsovo B-52, 
and proechymis LT 796 . 
Passive Protection Studies 
Five hamsters were injected ip with 0 . 5 ml of undiluted hybridoma 
culture fluid containing the 2D7 MAb. Five hamsters (control group) 
received an equal volume of sterile hybridoma culture medium . Both groups 
of hamsters were challenged 24 h later wi th 0.25 ml of liver suspensions 
from hamsters infected with type kennewicki (10 to 10,000 hamster LD~' s as 
determined by titration) (1). In a separate study, fi ve groups of hamsters 
(five per group) were each vaccinated ip with 0.5 ml of a serial 5- fold 
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(1:5 to 1:3125) dilution of the 207 MAb. Five hamsters were given an equal 
volume of hybridoma fluid prepared against Pasteurella multocida Type D 
dermonecrotic toxoid (NVSL). Challenge procedures were performed as 
outlined above. 
Western Blotting 
Triton X-100 extracted antigens of serovar pomona type kennewicki, 
and inactivated whole cells of serovars canicola, icterohaemorrhagiae, 
grippotyphosa, and pomona were separated on a 14% homogeneous separation 
gel (4% stacking gel) using a mini-electrophoresis system (Schleicher & 
Schuell, Keene NH). Extracted antigens were treated with sample buffer 
containing 0.05% 2-mercaptoethanol and 2% SOS. Samples were not boiled 
prior to electrophoresis. Electrophoresis was carried out at 30 mA for 
1.5 h. Separated antigens were electro-transferred to nitrocellulose 
membrane (Millipore Corp., Bedford, MA) at 100 mA for 2 h in buffer 
containing 12 mM tris and 96 mM glycine (pH 8.3). After transfer, the 
membrane was rinsed in distilled water and placed into a 1:80 dilution (in 
PBS containing 0.05% Tween) of a scites fluid containing the 207 monoclonal 
antibodies. After rinsing with distilled water, the membrane was placed 
into a 1:1000 dilution (in PBST ) of affinity purified pe r oxidase labeled 
goat anti-mouse IgA. After rinsing in distilled water, t he membrane was 
placed in a solution of 4-chloronaphthol (Sigma Chemical Co. , St. Louis, 
MO) for 10-15 min. 
Antigen Extinction Studies 
Antigen extinction studies were performed using selected bacterins in 
order to determine the end-point of protection. Hamsters were vaccinated 
intramuscularly with 0. 25 1i"1l of cne of five 5 ·fold dilut.ion!:l (in 
physiologic saline) of two commercial monovalent bacterins (bacterins 5649 
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and 9866) or the NVSL reference L. pomona bacterin. All thr~e bacterins 
were 2-ml-dose products. Each 0 . 25 ml of the initial dilution contained 
1/800 of the host-animal dose. There were 10 hamsters per dilution per 
bacterin. Fourteen days later, hamsters were challenged with virulent 
L. pomona organisms. Results were expressed as the protective dose at 
which a minimum of 80% of the hamsters survived an intraperitoneal 
challenge of 10 to 10,000 LO~'s (1). 
ELISA Procedure 
Polyclonal hyperimmune rabbit antiserum (prepared against 
L. interrogans serovar pomona type kennewicki) was diluted 1:100 in coating 
buffer (pH 9.6). Immulon-2 96-well mlcrotitration plates were coated with 
100 µl of the diluted rabbit antisera per well, and the plates were 
incubated at 4° C overnight. The antiserum was aspirated, 300 µl of 
blocking solution was added to all wells, and the plates were incubated for 
1 h at 37° C on an orbital shaker. The plates were washed once with 
disti lled water, and 100 µl of 2-fold dilutions of bacterins and the test 
reference were added to duplicate wells beginning with a 1:2 dilution. The 
NVSL reference pomona bacterin served as the test reference and was diluted 
at 1:7, 1:14, 1:21, and 1:35 with distilled water. These dilutions were 
considered to be undiluted and were used in the ELISA protocol for 1-, 2-, 
3-, and 5-ml dose products, respectively. Plates were incubated for 1 h at 
37° C on an orbital shaker. After washing three times (with distilled 
water), 100 µl of a 1:2000 dilution of 207 ascites fluid was added to all 
wells, and the plate was incubated on an orbital shaker at 37° C for l h. 
The plate was washed (with distilled water) three times to remove unbound 
207 MAb, 100 µl of a 1:1000 dilution of goat anti-mouse IgA (a) 
horseradish-peroxidase conjugate was added to all wells, and the plate was 
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incubated for 40 minutes at 37° C on an orbital shaker. After three washes 
(with distilled water), 100 µl of TMB was added to all wells, and the plate 
was incubated for 5 minutes at room temperature on an orbital shaker. The 
color reaction was stopped with 2.5 M sulfuric acid. The plate was read at 
a dual absorbance of 450/650 nm (Vmax Microtiter Reader, Molecular Devices, 
Inc., Menlo Park, CA). 
Data Analysis 
The mean OD for all blank wells was determined, and that value was 
subtracted from all sample OD values prior to data a nalysis. Linear 
regression and relative potency (RP) were calculated according to the NVSL 
RelPot Program (version 2.0). This program is designed to assign weight to 
linear regression lines for both a reference and a test sample. Slopes 
were checked for parallelism, and the relative potency calculations were 
made. Only the top three RP v alues were reported by the RelPot Program. 
For more information regarding the RelPot Program and availability, 
interested persons may contact the National Veterinary Services 
Laboratories, Veterinary services, Animal and Plant Health Inspection 
Service, Ames, IA., 50010, USA. Criteria for a valid test were: a) a 
simple linear regression line must be fitted to a minimum of three 
contiguous dilutions, and b) lines must have a correlation coefficient (r) 
of at least 0.95. Any bacterin yielding an RP of 1.0 or greater is of 
equal or greater potency as compared to the reference bacterin. 
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RESULTS 
The 207 hybridoma clone was shown to secrete IgA antibody 
(474 mg/ml) and was shown to react with a single antigen of approximately 
14 to 16 k.Da by western blot analysis using inactivated whole cells of 
serovar pomona type kennewicki (Figure 1). Monoclonal antibody 207 failed 
to react with antigens in whole cell preparations of the remaining 
leptospiral serovars. The 207 MAb also reacted with a single antigen of 
approximately 18 k.Da in the Triton X-100 extract preparation. 
The 207 MAb was specific for most but not all members of the 
serogroup Pomona when tested with inactivated whole cells of six Leptospira 
serogroups by ELISA. No cross reactivities were observed among serovars 
canicola, icterohaemorrhagiae, grippotyphosa, hardjo 11601, or 
bratislava 2a (Figure 2). Cross reactivity of the 207 MAb to six pomona 
serovars within the serogroup Pomona, inciuaing serovar pomona type 
kennewicki, is shown in Figure 3. Only two serovars, mozdok and tropica, 
failed to react with the 207 ascites fluid. Results from MAT studies were 
consistent with ELISA results using viable cells of seven hamster virulent 
L. interrogans serovars (Tables 1 & 2). In the hamster protection studies, 
the 207 MAb provided passive protection against a homologous challenge, but 
failed to protect hamsters from heterologous challenges (Table 3). 
In order to determine the end-point of protection produced by 
licensed leptospiral bacterins in hamsters, the NVSL reference L. pomona 
bacterin, a monovalent adjuvanted product (bacterin 5649), and a 
monovalent nonadjuvanted product (bacterin 9866) were evaluated in 
hamsters. Results of the an~1gc~ extinctio~ otudies are sh0w~ in Table 4. 
The protective dose at which 50% of the hamsters died (PD~) were 1:10,000, 
1:35,000, and 1:40,000 for bacterin 5649, the NVSL reference L. pomona 
bacterin, and bacterin 9866, respectively . 
Leptospiral bacterins evaluated by the ELISA represented 1-, 2-, 3-, 
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and 5-ml dose products (Table 5). Al l commercial bacterins tested at the 
recommended host-animal dose yie l ded relative potency (RP) values of 1 .0 o r 
greater. When tested at dilutions corresponding to a ntigen extinction 
values, no color development wa s noted. However, when doubling dilutions 
of these products were tested beginning with a 1:2 dilution, there was 
sufficient color development with an RP of ~ 1.0 for all products tested. 
Figure 1 . Western blot using the 207 MAb to detect antigen in various 
cellular preparations. A 14% acrylamide gel was used to separate boiled 
antigens (SO µg of protein per l a ne ). After electro-transfer, the 
membranes were probed with the 207 ascites fluid according to the protocol 
described in the Materials and Methods section . Lanes 1, 2: 
L . icterohaemorrhagiae whole cells , Lanes 3,4: L. grippotyph osa whole 
ce lls , Lanes 5,6: L. canicola whole cells, Lanes 7,8: L . pomona Triton X-
100 extract, Lane 9: L. pomona whole cells, Lane 10: pre-stained l ow 
molecular weight standard s . 
LI-
LZ-
6£-
os-
SL-
0£1-
~ 
01 6 
. J---
8 L 9 s 
I 
Figure 2 . Reactivity of the ascit es fluid containing MAb 207 with six 
inactivated whole cel l s of Leptospira interrogans serovars. Inactivated 
whole cells were diluted 1:100 a nd captured by t he polyclona l anti- pomona 
r abbit serum as described in the Materials and Methods section . A 1 : 2000 
dilut i on of the 207 ascites fluid was added f o llowed by a 1 :1000 dilution 
of horseradis h peroxidase-conjugated goat anti-mouse IgA (a-chain 
specific) . The substrate was 3 , 3', S, 5' -tetramethylbenzidine (TMB) . 
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Figure 3. Cross r eactivity of ascites fluid containing MAb 207 to six 
pomona serovars including serovar pomona type kennewicki. Heat- inactivated 
whole cells were diluted 1:100 and captured by the polylconal rabbit anti-
pomona serum as described in the Materials and Methods section. A 1:2000 
dilution of the 207 ascites fluid was added followed by a 1 :1000 dilution 
of horseradish peroxidase-conjugated goat anti-mouse IgA ( a-chain 
specific). The subtrate was 3, 3' , 5 , 5 ' -tetramethylbenzidine (TMB). 
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Table 1. Microagglutination 
titers {MAT) of the 207 
MAb f o r various sero-
varR of L. interrogans 
Antigen• MAT Titer6 
Pomona 10240 
Canicola <20 
Grippotyphosa <20 
Icterohaemorrhagiae <20 
Hardjo <20 
Bratislava 2a <20 
Bratislava jez <20 
a 
b 
Viable whole cells of hamster 
vir ulent ser ovars o f L . interrogans 
were used as the antigen. 
Titer is expressed as the recipr0~al 
dilution at which 50% of the 
leptospires were agglutinated . 
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Table 2. Specificity of the 207 MAb 
among p omona serovars of Sero-
group Pomona by the microagglu-
tination test 
Antigen• MAT Titer6 
L. pomona type ken newicki 102 6 10240 
L . pomona pomona 10240 
L . pomona proechymis LT 796 5120 
L. pomona tsaratsovo 8- 52 640 
L. pomona kunming KS 320 
L. pomona mozdok 5621 <20 
L. pomona tropica CZ 299U <20 
a Viable whole cells of each serovar wer e 
used as the antigen. 
b Titer is expressed as the reciprocal 
dilut ion at which 50% of the leptospir es 
were agglutinated . 
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Table 3. Passive protection of hamsters with the 207 MAb against a virulent 
challenge of serovar pomona type kennewicki, Icterohaemorrhagiae, 
Canicola, or Grippotyphosa a 
Hamsters Surviving Hamsters Surviving 
Homologous Challenge Beterologous Challengeb 
Dilution of 207 MJ\b (ty~e k enn ewick i ) (.J_L_ (C) (G) (ONT) 
undiluted 5/5• 0/5 0/5 0/5 0/5 
1 : 5 5/5 0/5 0/5 1/5 0/5 
1:25 3/5 0/5 1/5 0/5 0/5 
1:125 3/5 0/5 0/5 0/5 0/5 
1:625 3/5 0/5 0/5 0/5 0/5 
1 : 3125 0/5 1/5 0/5 0/5 0/5 
Hamsters were vaccinated with the 207 MAb and cha llenged 24 h later with 
virulent organisms. As a control , a MAb prepared against Pasteurella 
multocida Type 0 ONT was also used to vaccinate hamsters 
b Results are expressed as survivors/total. 
Heterologous L. interrogans serovars Icterhaemorrhagiae (I), Canicola 
(C), and Grippotyphosa !G). RPsults usi~g ths P. multoci da ONT MAb are 
also given. 
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Table 4. Comparison of PD~ values 
and RP values of three 
2-ml-dose products 
Bacterin 
5649 
fQs~ 
10,000 
RP Ranqe6 
8.23-9.98 
NVSL 35,000 17.24-19.53 
• 
b 
c 
40,000 27.40-29 . 52 
The protective dose at which 50% 
of vaccinated hamsters survive a 
virulent challenge. 
ELISA relative potency (RP) values 
of each bacterin against the 
ELISA reference bacterin. Relative 
potencies were calculated with the 
NVSL RelPot c0mputer program. The 
top three RP values are shown. 
Non-adjuvanted product. 
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Table 5. Bacterins eva l uated for relative potency 
by ELISA a 
Total No . Products Host Animal Dose No . Firms 
• 
b 
1 1 ml dose 1 
30 2 ml dose 8 
3 3 ml dose 1 
50 5 ml dose 6 
NVSL (TR)b 2 ml dose 
A total of 84 random bacterin samples were 
evaluated by the EL I SA system described in 
Materials and Methods. 
The NVSL reference L . pomona bacterin was used as 
the test reference (TR) and was evaluated against 
its elf in the ELISA system. 
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DISCUSSION 
The utilization of an in vitro assay for measuring the potency of 
L. interrogans serovar pomona bacterins is advantageous in reducing animal 
costs and lowering the risks to human health associated with the current 
test methods for leptospiral bacterins . This ELISA system, which utilizes 
a MAb specific for serogroup Pomona, was developed for this purpose. 
The anti-Leptospira MAb (207) utilized in this assay system is 
agglutinating (Tables 1 & 2) and protective (Table 3). This is 
advantageous for testing bacterin potency since agglutinating antibodies 
have been shown to be involved in the protective humeral response to 
infection (4,16,20-27). It is assumed that the outer envelope of the 
organism possesses epitopes against which protective antibodies are 
directed. Opsonization and agglutination would facilitate phagocytosis of 
the leptospires by macrophages and polymorphonuclear lymphocytes. 
Antigen extinction studies in hamsters were utilized to determine the 
end-point of protection produced by the NVSL L. pomona reference bacterin 
and two monovalent bacterins (Table 4). Results from this study emphasize 
the high sensitivity of the hamster model. In the current hamster model, 
L. pomona bacterins are diluted to 1/800 of the host-animal dose and used 
to vaccinate hamsters. From the antigen extinction studies, many of these 
bacterins may conceivably be diluted 1:40,000 and still elicit a protective 
response against a virulent challenge in the hamster model. Although 
hamsters are extremely sensitive to leptospiral challenge, the sensitivity 
of this ELISA-based system closely parallels the hamster model. It is 
assumed that bacterins that fail the hamster potency test should also fail 
when tested by ELISA. It is noteworthy that the nonadjuvanted bacterin 
(9866) and the adjuvanted NVSL reference L. pomona bacterin yielded similar 
PD~ and RP values (Table 4). This suggests that adjuvant does not 
interfere with the performance of the ELISA-based system to detect 
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L. pomona antigen in these 2-ml-dose products. 
The use of this ELISA provides a reproducible alternate method for 
testing the L. pomona component of bacterins. In addition, this test 
system could be used for diagnostic purposes, such as screening of master 
seed cultures used in the manufacture of leptospiral bacterins and for 
screening cultures for cross-contamination by other L. interrogans 
serovars. Other assays currently being developed in this laboratory to 
measure antigen(s) of serovars canicola and grippotyphosa will provide 
additional in vitro testing methods for the evaluation of leptospira 
bacterins and reduce even further the need for in vivo testing of these 
products. 
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APPENDIX A: LABELING OF THE 207 MAB 
WITH HORSERADISH PEROXIDASE 
Saturated anunonium sulfate [(NH4 )iS04 ) was prepared by dissolving 
550 g of pure (NH4 ) 2S04 (reagent grade, Fisher Scientific, Fair Lawn, NJ) in 
1 liter of distilled water. Sodium bicarbonate (0.3 M) was prepared by 
dissolving 1 .26 g of NaHC03 in 50 ml distilled water. Fluorodinitrobenzene 
(1%) was prepared by adding 0.5 ml of 1-fluoro 2,4-dinitrobenzene 
(FC~3 )N02 ) 2 (Sigma Chemical Co., St. Louis, MO) to 49.5 ml of absolute 
alcohol. Sodium periodate (0.08 M) was prepared by dissolving 0.856 g of 
NaI04 in 50 ml distilled water. Ethylene glycol (0.16 M) was prepared by 
adding 0.45 ml of ethylene glycol to 49.55 ml of distilled water. A stock 
solution of 0.1 M carbonate-bicarbonate buffer (pH 9.5) was prepared by 
mixing 9 parts of a 0. 1 M Na2C03 solution to 28 parts of a 0. 1 M NaHC03 
solution and diluting the mixture 1:10 with distilled water. The 0 .1 M 
Na2C03 stock solution was prepared by dissolving 10. 6 g Na2C03 in 1 liter of 
distilled water and the pH was adjusted to 11.2. The 0.1 M NaHC03 stock 
solution was prepared by dissolving 8 .4 g NaHC03 to 1 liter of distilled 
water and the pH was adjusted to 8.1. A 0.85% saline solution was prepared 
by dissolving 8.5 g NaCl in 1 liter of distilled water and the pH was 
adjusted to 8.0. 
Horseradish peroxidase solution (HRP) was prepared by dissolving 
50 mg HRP (Rz factor of 3.2, Sigma Chemical Co ., St. Louis, MO) in 10 ml of 
a 0.3 M sodium bicarbonate solution. One milliliter of the 1% 
fluorodinitrobenzine (Sigma Chemical Co., St. Louis, MO) solution was added 
and allowed to incubate on a r otary shaker (10-20 rpm) for 1 h. Te n 
milliliters of a 0.8 M sodium periodate solution was added and incubated 
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for 30 min on a rotary shaker . Ten milliliters of 0.16 M ethylene glycol 
was added and incubated for 1 h on a rotary shaker. The HRP solution was 
dialized against 2 liters of 0.01 M carbonate buffer (pH 9 . 5) for 5 days 
with a total of eight changes of buffer. The HRP solution was filter 
sterilized with a 0.45 µm filter . 
Delipidization of Ascites Fluid 
Twenty milliliters of ascites fluid containing the 207 MAbs were 
filte red through a 0.45 µm filter (Millipore Corp., Bedford, MA) and 0.4 ml 
of a 10% solution of dextran sulfate was added in a drop- wise manner . The 
mixture was incubated at room temperature (25° C) f o r 30 min stirring 
occasionally. Two milliliters of a 1 M cacl2 solution was slowly added to 
the ascites fluid and incubated at room temperature for 15 min with 
occass ional stirring. The mixture was centrifuged at 12 , 000 x g at 4° C 
for 30 min and the supernatant was collected without disturbing the pellet. 
The pellet was discarded. 
Immunoglobulin Fractionation and HRP Labeling 
The supernatant from delipidization was fractionated with three 
successive fractionations of 50%, 45%, and 45% saturated ammonium sulfate. 
For each fractionation, the ammonium sulfate was added in a drop-wise 
manner while stirring in an ice bath. The mixture was stirred for 30 min 
at room termperature and then centrifuged at 10,000 x g for 30 min at 4° c. 
The s upernatant was discarded. The pellet was rinsed with distilled water 
and resuspended in 20 ml distilled water (pH 7.5). After the final 
fractionation, the pellet was resuspended to one- half the original volume 
(10 ml) with distilled water (pH 7.5). 
The globulin- containing solution was placed in a dialysis bag and 
dialized against several changes of 0.85% saline until the dialysate was 
4 1 
free o f s u l fate ion (72 h) . The dialysate was checked for the presence of 
sulfate ion by adding 1 ml of dialysate to 1 ml of saturated barium 
chloride (BaCl) . When the dialysate was free of sulfate ions, the 
globulin-containing solution was centrifuged at 10,000 x g for 30 min at 
4° c and f i lter sterilized with a 0.45 µm filter. A 1 ml sample of the 
globulin- containing solution was removed and used for protein determination 
using a Paragon Electrophoresis Kit SPE (Beckman, Palo Alto, CA). There 
were 16.4 mg protein/ml globulin p resent. The globulin-containing solution 
was dialyzed against eight change& of 0.01 H ~arbonate ouffer (pH 9.5) fo r 
5 days at 4° c. 
Immunoglobu l in Labeling 
After the globulin-conta i ning solution and the HRP solution were 
dialyzed, 3.5 ml of globulin-containing solution was added to 17.2 ml HRP 
solution. The mixture was allowed to rotate slowly at room temperature f o r 
3 h. The 207 HRP-conjugated antibody was dispensed into 20 µl aliquots and 
stored at 4° C until use. 
Results 
Several attempts wer~ ilinde to obtair. a ~ta0le 2D7 HRP conjugate. All 
attempts f a iled. We were able to conjugate the MAb, but the stability was 
poor. Initially, similar OD values were obtained using the 207 conjugate 
as compared to the two-step detection method (Figure Al). However, over a 
one month period, the OD values decreased until there was no difference 
between OD values obtained using the 2D7 conjugate and background values. 
Based on these results, no furthe r attempts at conjugation of the 2D7 MAbs 
were made. 
Figure Al. Stability of the 207 HRP conjugate. The 207 HRP conjugate was 
used in the ELISA protocol at a 1:1000 dilution. The assay was performed 
on four separate occassions using the NVSL reference L. pomona bacterin. 
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Discussion 
Antibodies can be tagged with a variety of labels. Each choice of 
label has advantages and disadvantages over the use of other labels. The 
most widely used labeling process involves covalently coupling the antibody 
to enzymes (79-83). The ideal result for any coupling reaction is a 1:1 
ratio of antibody to enzyme with no loss of specific activity of either 
partner. This has not been achieved. Advantages with the use of enzyme-
labeled antibodies include a) a long shelf life, b) high sensitivity, and 
c) the label is applicable at the electron microscopic level (84). Some of 
the disadvantages with using enzyme-labeled antibodies are: a) there are 
multiple steps involved in the labeling, b) some enzyme substrates are 
hazardous, and c) the presence of endogenous enzymes may interfere with the 
labeling process or enzyme-substrate reactions. 
A large number of enzymes have been used to label antibodies. The 
most commonly used are horseradish peroxidase (HRP), alkaline phosphatase, 
and fi-galactosidase. Two methods commonly used for the preparation of 
antibody-peroxidas~ conjugates are the two-step glutaraldehyde method and 
the periodate method. The two-step glutaraldehyde method has a relatively 
low coupling efficiency. This is due to the methodology in that 
glutaraldehyde is first coupled to pure horeseradish peroxidase (HRP) via 
the relatively few reactive amino groups available on the enzyme. After 
purification, the HRP-glutaraldehyde mixture is added to the antibody 
solution. This requires that the HRP-antibody conjugates be separated from 
unconjugated material for optimum sensitivity (85-87). As with any 
peroxidase labeling method, the HRP must be pure to minimize cross-linking 
of the enzyme molecules to contaminating proteins during the first step of 
the procedure. The periodate method involves treatment of carbohydrates on 
the antibody molecules. The periodate opens the ring structure and allows 
the periodate to bind to free amino groups. Coupling antibodies and HRP 
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with periodate linkage is an efficient method (88,89). 
In this experiment, we labeled the 207 MAbs with HRP by the periodate 
method. However, we were not able to obtain a stable product. There are 
several reasons why the peroxidase label was not stable. First, monoclonal 
antibodies from ascites fluid usually contains contaminating mouse serum 
proteins. Between 2 and 10% of the antibodies from ascitic fluid will be 
from the mouse antibody repertoire and not from the hybridoma (90). These 
contaminating proteins may have interfered with the perioxidation and 
labeling of the 207 MAbs, resulting in less efficient labeling of the MAb. 
Associated with the presence of antibodies from the mouse ' s antibody 
repertoire, is the possibility of varying immunoglobulin size and 
carbohydrate differences between the myeloma-derived and mouse-derived 
antibodies that are contained within the ascites fluid. The percentages of 
the ammonium sulfate fractionations may have precipitated a significant 
amount of mouse antibodies normally present in the ascites fluid. If this 
occured to any extent, these antibodies would have been labeled in the 
process as well. To my knowledge, there is no literature to indicate that 
myeloma-derived and mouse-derived antibodies differ in the ability to 
covalently bind an enzyme label. 
A third explanation for the poor stabilization of the labeled MAb has 
to deal with the carbohydrate moieties present on immunoglobulins. 
Carbohydrate chains of variable length and shape are almost always 
associated with immunoglobulins (91). The chains can be either simple or 
branched and may consist ot only ~wo sugar residues. However, most 
immunoglobulins contain at least a dozen or more units (91). The number of 
carbohydrate chains attached to a single immunoglubin molecule varies, 
depending on the isotope of the antibody: IgG contains two carbohydrates 
chains per molucule, IgM 10, IgA 16, Igo 6, and IgE 12. It is possibile 
that even molcules of the same class and subclass can vary their 
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carbohydrate content. 
A fourth explanation for the lack of stability is that under normal 
conditions, carbohydrate chains attach to the Fe portion of the antibody 
molecule, but under pathological conditions carbohydrates can also be found 
attached to light (L) chains and to variable (V) regions of heavy (H) 
chains. Carbohydrate groups present in the V region are inaccessible 
because they are buried in the interior of the molecule. Because the 207 
MAb is derived from a myelc.ima cell, it is posaible that the number and 
distribution of carbohydrate moieties are unusual. Because the periodate 
method was used to peroxidase label the 207 MAb, a change in the amount of 
available carbohydrate content would affect the labeling process and 
stability. A change in the amount of avaliable carbohydrate may be due to 
a portion of carbohydrate being buried in the interior of the molecule, or 
there may be very little carbohydrate present at all. There is also the 
possibility that the delipidization or any other stage involved in the 
labeling process may have destroyed potential reactive groups on the 
immunoglobulin molecule . 
If labeling monolconal antibodies with any of the conventional 
techniques causes loss of activity, one convenient f••=th~d for preparing 
tagged antibodies is to label the primary amino acid chain by growing the 
hybridomas in the presence of radioactive precursors (92). This can only 
be done with antibodies for which the hybridoma cells are available, but 
the resulting antibodies have a number of potentially important properties, 
the most of which is that the labeled antibodies will be essentially 
identical to the unlabeled proteins. 
Procedure 
SOS-PAGE 
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APPENDI X B: CHARACTERIZATI ON OF THE ANTIGEN 
RECOGNIZED BY THE L. POMONA 2D7 MAB 
Whole cell preparations used for sos electrophoresis and western 
blotting procedures were prepared by growing serovars canicola, 
grippotyphosa , icterohaemorrhagiae, and pomona to a density of 1 x 106 
organisms/ml. Ten milliliters of each of these cultures were placed in a 
56° C water bath for 30 min to inactivate the organisms. The cultures were 
centrifuged at 12,000 x g f o r 30 min at 4° C and the pellets were washed 
three times with sterile PBS (pH 7.2 ) . After the final wash, the pellets 
were resu spended in 2 ml PBS (pH 7.2). These suspensions were used in sos-
PAGE and immunoblot studies. Protein concentrations were determined using 
a BCA protein determination kit (Pierce, Rockford, IL). 
Inactivated whole cells and/or Triton X-100 extracted antigens (50 µg 
protein) of each of serovars canicola, grippotyphosa, icterohaemorrhagiae, 
and pomona type kennewicki were separated using a mini-electrophoresis 
system and prepared gels (Schleicher & Schuell, Keene, NH). Samples were 
treated with sample buffer containing 0.05% 2-mercaptoethanol and 2% sos. 
Samples were boiled for 5 min at 100° C prior to electrophoresis. 
Electrophoresis was carried out on a 14% homogeneous gel with a 4% stacking 
gel at 30 mA per gel f or 1.5 h. Gels were stained with either a silver 
nitrate stain for lipopolysaccharide (LPS) o r with Coomassie Brilliant Blue 
for protein. The migration distances of the bands contained within the gel 
matrix were determined using~ l~~er densit0m~ter (Pharmacia-LKB). 
Molecular mass markers (Bio-Rad) were used to calculate the apparent 
molecular mass of the antige ns. 
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Silver Stain for Lipopolysaccharide CLPSl 
Polyacrylarnide gels were stained f o r LPS using a modified silver 
stain (93) . Briefly, LPS in the gels was oxidized without prior fixation 
with a 0.7% (w/v) periodic acid in 40% ethanol a nd 5% acetic acid for 20 
min at 22° c . After three washes (5 min each) in d istilled water, the gels 
were incubated in fresh staining solution for 10 min at 22° C. The 
staining solution was prepared by adding 4 ml of concentrated ammonium 
hydroxide (29.4%) to 56 ml of a 0.1 M s odium hydroxide solution. After 
adding 200 ml of distilled water, 10 ml of a 20% (w/v) solution of silver 
nitrate (in distilled water) was added d ropwise while stirring. After 
washing the gel three times (5 min each) with distilled water, the color 
development solution was added. The color development solution was 
prepared by adding 0.1 ml of a 37% formaldehyde solution to 200 ml of 
distilled water containing 10 mg of citric acid. The color development was 
allowed to proceed for approximately 10 min at 22° C and the reaction was 
stopped by exposure of the gel to 10% acetic acid for 1 min followed by 
several washings in distilled water. 
Western Blotting 
After separation, gel-bound antigens were transfered to 
nitrocellulose membrane (Millipore Corp. , Bedford, MA) overnight (16-20 h) 
at 20 mA in buffer containing 12 mM tris and 96 mM glycine (pH 8.3) . After 
transfer, the membrane was placed directly into a 1: 80 dilution of ascites 
fluid containing the 207 monoclonal antibodies. After incubating at 37° c 
for 1 h on an orbital shaker, the membrane was rinsed 3 times with 
distilled water and incubated as before in a 1:1000 dilution of affinity 
purified peroxidase labeled goat anti-mouse IgA . After rinsing the 
membrane in distilled water 4 times, the membrane was incubated in 4-
chloronaphthol (Sigma Chemical Co., St. Louis, MO) f or 10-15 min at r oom 
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temperature . 
Biochemical Determination of the Epitope by Proteinase K Digestion 
In this experiment, heat-inactivated whole cells of serovars 
canicola, grippotyphosa, ict~~ohe~morrhagiac, and pomond (SO µg of protein 
each) were treated with proteinase K prior to electrophoresis . Paired non-
treated samples were also used. Samples were separated into 2 identical 
8 - 16% SOS-PAGE grandient gels with a 4% stacking gel (Schleicher and 
Schuell). After electrophoresis, one gel was stained with Coomassie 
Brilliant Blue for protein. The antigens contained in the second gel were 
electro-transfered to nitrocellulose membrane and then probed with the 207 
ascites fluid as described previously. Treated and non-treated samples 
were also evaluated in the L. pomona ELISA. 
Results 
The 207 hybridoma clan~ w~s shown to ~ecrete IgA antibody using a 
commercial isotype ELISA kit. Heat-inactivated whole cells and Triton X-
100 extracts of serovars canicola , grippotyphosa, icterohaemorrhagiae , and 
pomona type kennewicki were separated by SOS gel electrophoresis. The gels 
were either stained for protein, LPS, or were subsequently electro-
transfered to nitrocellulose membranes. The membranes were then probed 
with the 207 ascites fluid as previously described. Results demonstrated 
that the 207 ascites fluid contained monoc l onal antibodies specific for a 
14-16 kDa antigen in the Triton X-100 extract of serovar pomon a (Figure 
Bl). The monoclonals also reacted to a single antigen of approximately 18 
kDa in the whole cell preparation. The monoclonal antibodies contained 
within t he 207 ascites fluid failed to recognize anligeP. in whole cell 
preparations of the remaining leptospiral serovars. 
Although LPS-silver stained gels indicate that the 207 MAbs detect an 
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epitope on a 16 kDa Triton-extracted antigen that is predominantly LPS-like 
in nature, this LPS-like antigenic moiety may be associated with protein. 
Thie antigen is faintly stained by both LPS-silver stain (Figure B2) as 
well as by Coomassie stain (Figure B3) . The epitope on the 18 kDa antigen 
detected by the 207 MAbs in inactivated whole cell preparations shows 
similar staining properties. When samples were treated with proteinase K, 
there was a lack of staining by Coomassie Brilliant Blue in treated samples 
except for one faintly staining antigen of approximately 16 to 18 kDa 
(Figure B4). In Figure BS, the 207 MAbs detected tne same epitopes on 
inactivated whole cells and the Triton extracted antigens whether they were 
treated or not treated with proteinase K. The 207 MAb detected an epitope 
on the same antigenic moiety in proteinase digested samples as well as in 
non-treated samples. When tested by the ELISA, proteinase-treated samples 
yielded slightly higher OD values as compared to non-treated samples (data 
not shown). 
Figure Bl . Immunoblot using the 207 MAb to detect antigen in various 
antigen preparations. A 14\ homogeneous gel was used to separate boi l ed 
antigens (50 µg of protein per lane). After electro-transfer , the 
membranes were probed with the 207 ascites fluid according to the protocol 
descr ibed in the Materials and Methods section . Lanes 1,2: 
L . icterohaemorrhagiae whole cells, Lanes 3,4: L. grippotyphosa whole cells 
(25 µl), Lanes 5,6: L . canicola whole cells, Lanes 7 , 8 : L. pomona Triton X-
100 extract, Lane 9: L. pomona whole cells, Lane 10 : pre- stained low 
molecular mass stanndards (8 µl). 
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Figure B2. LPS silver stained gel containing inactivated whole cells and 
the Trito n X-100 extract of serovar pomona . Boiled samples (SO µg of 
protein per lane) were separated into a 14% sos gel with a 4% stacking gel. 
Afte r separation, the gel was stained for LPS using a modified silver 
stain. Lane 1: pre-stained low molecular mass markers , Lane 2 : L . p omona 
Triton X-100 extract, and Lane 3: L. pomona inactivated whole cells. 
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Figure B3. Coomassie Brilliant Blue stain of Triton X-100 extracts of 
serovars canicola and pomona. Boiled samples (50 µg of protein per l a ne) 
were separat e d into a 14% homogenous SOS polyacrylamide gel with a 4% 
stacking ge l. Lane 1: pre-stained low molecular mas s markers , Lane 2 : 
L . canicola Triton X-100 extr act , Lane 3: L. pomona Triton X-100 extract , 
Lane 4: blank, Lane 5: L. canicola inactivated whole cells , and Lane 6 : 
L . pomona inactivated whole cells. 
-ll 
-LZ 
-6£ 
-OS 
-SL 
-0£1 
9 
s 
£ 
I 
9!0 
Figu re B4. Comassie Brilliant Blue stain of inactivated whole cells of 
serovars canicola 1 grippotyphosa, icterohaemorrhagiae, and pomona . Bo iled 
samples were treated with proteinase K prior to electrophoresis and were 
loaded (SO µg of protein per lane ) in the same orde r o nto identical 14% SOS 
polyacrylamide gels . Paired, non-treated control samples were also used. 
After e l ectrophoresis, one gel was stained with Coomass i e Brilliant Blue . 
Lane l : L . pomona inactivated whole cells, Lane 2 : L. pomona Trtion X-100 
extract , Lane 3 : L . can icola inact ivated whole cells, Lane 4: L . canicola 
Trtion X-100 extract, Lane 5: pre-stained low molecular mass markers. 
Samples in lanes 1-4 wer e not treated with proteinase K. Lanes 6-9 contain 
samples in the order given for lanes 1-4 but were treated with proteinase K 
prior to electrophoresis . 
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Figu re BS . Western blot of inactivated whole cells of serovars canicola, 
grippotyophosa, icterohaemorrhagiae, and pomona. Boiled samples (SO µg of 
protein per lane) were treated with proteinase K prior to electrophoresis 
and were separated (SO µg o f pro tein per lane) into a 14% po lyacrylamide 
gel with a 4% stacking gel. Paired, non-treated control samples were also 
used. After electrophoresis, antigens in the gel were electro- transfered 
to nitrocellulose membrane and probed with the 207 ascites fluid as 
described in Materials and Methods. La ne 1: L. p omona inactivated whole 
cells, Lane 2: L . icteroha emorrhagiae inactivated whole cells, Lane 3: 
L . grippotyphosa inactivated whole cells, Lane 4: L. canicola inactivated 
whole cells , Lane S: blank, Lane 6: pre-stained low molecular mass markers. 
Samples in lanes 1- 4 were not treated with proteinase K. Lanes 7- 10 
contain samples as ordered in lanes 1-4 and were treated with proteinase K. 
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Discussion 
Based on the results of these studies, it is speculated that the 
epitope recognized by the 2D7 MAbs is associated with an antigen that is 
predominantly LPS-like in nature, although some protein may be associated 
with an LPS-like moiety. The 2D7 MAbs detected an epitope present on a 
Triton- extracted 16 kDa LPS-like moiety that may be associated with protein 
as well as an epitope present on an 18 kDa LPS-like moiety present on 
inactivated whole cells of serovar pomona type kennewicki (Figures 1, 2, 
and 3). The difference in the mass of the epitope-associated antigenic 
moieties detected in the two preparations may be partially explained by the 
extraction process itself. The antigenic moieties may be associated with 
other molecules (protein) present on the membrane surface. During 
extraction, a portion of this molecule is removed resulting in a lower 
molecular mass antigen. The 2 kDa difference between the two antigenic 
preparations may represent the removal of a membrane-anchoring molecule . 
The presence of the protein, a~ shown in Coomassie stained gels, may 
represent that part of the protein that is normally associated with this 
LPS-like moiety in the intact molecule. When the proteinase K-treated and 
non-treated samples were separated and transfered to nitrocellulose 
membrane and then probed with the 2D7 ascites fluid, the 2D7 MAbs detected 
epitopes on the same LPS-like moieties regardless of treatment (Figure 4). 
A second explanation is that the 18 kDa band may represent the 14-1 6 kDa in 
complex with an aggregation of post-translational gene products in response 
to the increased temperature used to inactivate the organisms . One must be 
cognizant of the fact that although the 2D7 MAbs react with a single 
epitope, more than one epitope is probably recognized during the immune 
response to L. pomona infecticn. Therefore, protection must be thought of 
in terms of more than one epitope. 
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Although these results are not conclusive for an LPS-like epitope, 
the presence of an LPS-like substance is consistent with previous r eports 
which indicate that leptospiral LPS differs from classical LPS (S , 11-15). 
Further work needs to be done in this area. The LPS silver stain technique 
used in this study probably stained some protein in addition to the LPS . 
Staining for LPS using a silver stain is unpredictable. Protein may have 
been stained due to either: a) fluctuations in room temperature during 
staining, or b) too much ammonium hydroxide in the color development 
solution. In order to better define this LPS-like substance, radioisotopic 
precursors could be included in the growth media. This would allow 
labeling of the sugars and prct~l11s during ~ruwth and would provide a more 
precise method of determining if the epitopes are a combination of an LPS-
like substance and protein . Additional work that may be performed include 
labeling the 207 MAb with colloidal gold and use this conjugate to 
determine whether the antigen is part of the flagella or the outer sheath. 
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APPENDIX C: L. POMONA ELISA EVALUATION 
Procedure and results 
ELISA Evaluation by Independent Laboratories 
Veterinary biological firms marketing leptospiral bacterins were 
invited to participate in thA evaluation of this as~ay using six coded 
licensed bacterins. Evaluation kit components included the test reference 
bacterin, two 3-ml dose bacterins (Cl and C2), two 5-ml dose bacterins (Dl 
and 02), and two negative bacterins containing no leptospires . Reagents 
included in the kit were ascites fluid containing the 207 monoclonal 
antibodies, and the hyperimmune rabbit capture serum. Participating firms 
were asked to assay each coded bacterin in triplicate according to the 
ELISA protocol and to provide their results and any comments to the NVSL. 
The submitted relative potencies, geometric means of the relative 
potencies, variances of the relative potencies , and standard deviations of 
the relative potencies were determined. Variances measuring each firm's 
in-house reproducibility were tested for homogeneity using Chi-squares . 
Ten biologics firms marketing leptospiral bacterins expressed 
interest in participating in an industry-wide evaluation of the L. pomona 
ELISA. Six of those ten firms have completed their evaluation and have 
returned data and comments. The mean RP values for each coded bacterin 
from each firm was determined and the natural log of that value used to 
graphically represent the data. Data generated by the NVSL on three 
separate occasions were treated in a similar manner. Relative potencies 
between the NVSL and firms were within reasonable values (Figure Cl). In 
general , results indicate that there was more varia~ion due to bacterin 
than due to firm. Although a significant Chi- square resulted, the 
variation was due to one firm's results for two o f the coded bacterins. 
This firm had large variances between replicates when assaying the 3-ml 
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dose bacterins (Figure C2) . Variances of the remaining firms were low. 
With the exception of the one firm, most firms h ad nearly c onsistent 
standa rd dev iations f or the bacterins tested (Figure C3) . Comments 
regarding the ELISA that were supplied to the NVSL include: 
1) "The ELISA i s very s peci f ic for L. pomona." 
2) "The ELISA i s easy to follow and straight-forward." 
3) "We feel ver y comfortable with t he protocol. " 
4) "The data is reproducible." 
5) "The 5 - ml dose product s are more cons istent as compared to the 3-ml 
dose products ." 
6) "I s t her e a possibility of an expanded dilution scheme?" 
7) "We would like to refrain from the use of TMB in our laborator y. " 
8) "Antigen elution is detrim~ntal to the a nt i gen being detected." 
Figure Cl. Relative potency values for coded bacterins Cl, C2, Dl, and 02 
obtained by the NVSL and participating firms. 
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Figure C2. Variances of relative potency values for coded bacterins Cl, 
C2 , 01, and 02 obtained by each participating firm. Variances were 
determined using Chi- squares . 
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Figure CJ. Standard deviations of relative potency values for coded 
bacterins Cl, C2, 01, and 02 obtained by each participating firm. 
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Discussion 
Whenever one is deal~~g wit~ a large in~ustry sue~ a$ the veterinary 
biologics industry, one must be cognizant that new advances are constantly 
being made in relation to a ntigen delivery and antigen process ing . In 
regards to the development of in vitro assays (i.e., ELISA) , a major 
concern is the type of adjuvants that are used in the production of a 
bacterin . Some biologics firms use a single adjuvant . Other s use a 
combination of adjuvants. Some adjuvants are superior to others and bind 
the antigen more tight l y than others. By far the most common adjuvant used 
for leptospiral bacter ins is aluminum hydroxide. When using a superior 
adjuvant, a smaller proportion of a given leptospiral serovar may be used. 
Not all biologics firms use the same amount of antigenic material in their 
products for a given serovar. Given this backgrou~a, it is not unusual f or 
there to be more variation due to bacterin than to firm. 
Dilutions of the test reference bacterin that are used in the ELISA 
protocol will protect hamsters against a virulent challenge. However, 
there is no color change when bacterins are used in the ELISA protocol at 
the dilutions set forth in the Code of Federal Regulations ( 1) . Because of 
the use of different adjuvants, it is difficult to develop an in vitro 
assay that correlates perfectly with the host animal. The best that we can 
do at this time is to approximate what the host animal recognizes as 
foreign in the bacterins. 
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APPENDIX D: CORRELATION OF THE L. POMONA 
ASSAY WITH THE IN VIVO ASSAY 
Procedure 
Ten serial two-fold dilutions (beginning with 1:3) of the NVSL 
reference L. pomona bacterin were prepared and diluted to 1/800th of the 
host animal dose according to established protocols (1). The diluted 
bacterins were used to vaccinate hamsters by intramuscular injection. The 
NVSL reference L. pomona bacterin was also evaluated undiluted. There were 
five hamsters per bacterin dilution as well as 10 nonvaccinated control 
hamsters . Two weeks later, hamsters were challenged (ip) with 0.25 ml of 
liver homogenates from L. pomona-infected hamsters (10 to 10,000 LDSO's as 
determined by titration (1)). Results were recorded as the number of 
survivors per total number of animals challenged. Dilutions of the NVSL 
reference L. pomona bacterin used in hamsters were evaluated by the 
L . pomona ELISA without diluting to 1:800th of the host animal dose. 
Results of the ELISA evaluation were expressed as the highest RP. 
Results and discussion 
The purpose of this experiment was to determine whether the L. pomona 
ELISA would detect an unsatisfactory bacterin . Serial two-fold dilutions 
of the NVSL reference L. pomona bacterin were prepared and used to 
vaccinate hamsters according to established protocols (1). The NVSL 
reference L. pomona bacterin was also evaluated without prior dilution. In 
the hamster potency assay, all bacterins tested for potency against 
L. pomona are diluted so that each hamster receives 1/800th of the host 
animal dose. The undiluted and diluted NVSL reference bacterins were also 
evaluated in the ELISA protocol without prior dilution to 1/800th of the 
host animal dose. 
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Results indicate that the ELISA approximates the hamster potency 
assay (Table Dl). Eighty percent of the hamsters were protected with 
a 1:24 dilution (1.224 x 105 organisms), whereas a 1:12 dilution 
(5.878 x 106 organisms) yielded an RP of 1.03. Dilutions of 1:48 and 
greater failed to protect hamsters. Dilutions of 1:24 and greater failed 
to yield an RP of 1.0 or greater in the ELISA. There are four reasons why 
protection was provided by more dilute bacterins as compared to the ELISA 
results: a) the hamster is not a natural reservior for leptospirosis and 
may be too sensitive for potency testing of leptospiral bacterins, b) 
there are other processes involv ed in the host immune response to 
vaccination that are not accounted for by the ELISA, c) the adjuvant 
(aluminum hydroxide ) allows for a slower release of antigen in the hamster 
as well as serving as a mild immunostimulant, and d) since the antigen is 
not eluted from the adjuvant, not all of the epitopes were available to 
bind to the 207 MAb. Becauee jt is not ~cssible to mimic dll aspects of 
the host immune response to leptospiral vaccination in vitro, it should not 
be suprising that the ELISA does not parallel the hamster potency assay 
exactly. 
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Table Dl. Comparis on of the hamster pote ncy assay and the ability of the 
L. pomona ELISA to detect an unsatisfactor y bacterin • 
Bacterin No. Organisms No . No. Organisms 
Dilution Injected Survivorsb Re1;1resentedc ELISA Results4 
Undiluted 5.875 x 107 5 /5(100%) 7.050 x 107 9.13 
1:3 1. 958 x 106 5 /5(100%) 2.35 1 x 107 5.45 
1 : 6 9.792 x 10s 5/5( 100%) 1.176 x 107 2.77 
1:12 4. 896 x 105 5 /5(100%) 5.878 x 106 1.03 
1:24 2.448 x 105 4/5( 80% ) 2 . 939 x 106 0.41 
1:48 1. 224 x 105 0/5(0%) 1. 4 70 x 106 NVC 
1:96 6 .119 x 104 0/5(0%) '7. 34 7 x 105 NVC 
1:192 3.060 x 104 0/5(0%) 3 . 673 x 105 NVC 
1:384 1. 530 x 104 0 /5(0%) 1. 837 x 105 NVC 
1 : 768 7.648 x 103 1 / 5(20% ) 9.184 x 104 NVC 
a The NVSL r eference L. pomona bacterin was diluted to l/800th of a 2-ml 
dose and used to vaccinate hamsters followed by a virulent L. pomona 
challenge two weeks later. The same bacterin was evaluated according to 
the ELISA protocol without prior dilution to l /800th of a 2-ml dose. 
b 
c 
d 
Number of hamsters surviving a virulent L. p omona challenge . Results 
are expressed as the number o f survivors per total number of animals 
challenged. 
Number of organisms used in the ELISA at a 1:2 dilution . 
Results are expressed as the highest RP values as determined by the 
RelPot computer program. NVC, no val id combinatio ns . 
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A.BS TRACT 
Licensing of leptospiral bacterins is currently based on a hamster 
potency assay in which a minimum of 80% of vaccinated hamst ers must survive 
a virulent challenge . The development of an in vitro assay would reduce 
the number of hamsters required for testing , wou l d decrease the potential 
for human exposure, and would be less expensive to the manufacturer and the 
National Veterinary Services Laboratories. Recently , an in vitro assay was 
developed for measuring the r elative potency of leptospiral bacterins 
containing L eptospira pomona. This report describes the development of a 
similar assay f or Leptospira canicola. Hybridomas were prepare d and 
screened by established protocols using a non-adjuvanted extract of the 
NVSL challenge strain of s~rovar canicola (Moulton &crai.n) of the Serogroup 
canicola. A canicola-specif ic clone, designated as 408, was chosen for 
further study based on the specificity o f hamster protection and reactivity 
to the homologous serovar and no reactivity to heterologous ser ovars by 
western blot studies. Monoclonal antibody 408 was not cross-reactive by 
ELISA with L. interrogans eerova rs grippotyphosa, hardjo, 
icterohaemorrhagiae, pomona , or bratislava. The potency assay i s a 
sandwich ELISA and involves capturing antigen from bacterins with anti-
canicola polyclonal rabbit sera , followed by the 408 ascites fluid, anti-
mouse IgM peroxidase-labeled antibody, and color substrate (ABTS). 
Bacterins adjuvanted with aluminum hydroxide or oi l require treatment to 
elute antigen from the adjuvant prior to use in th~ BLIS~ protocol. Non-
adjuvanted bacterins and bacterins containing adjuvants other than aluminum 
hydroxide or oil require no treatment prior to use in the ELISA protocol . 
The potency of 185 leptospiral bacterins, relative t o a reference bacterin, 
were evaluated with this ELISA. In order to be considered satisfactory, 
all bacterins must have a relative potency of 1.0 or greater. All 
bacterins tested passed the ELISA assay. 
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INTRODUCTION 
Leptospires occur naturally in a wide variety of feral an domestic 
mammals. In natural hosts, the spirochetes colonize in the kidneys and are 
shed in the urine. Humans are accidental hosts, with most infections 
related to occupational or r ecreational activities involving either direct 
contact with animal urine or contact with water and soil contaminated with 
animal uri ne. Leptospirosis in animals may be controlled by vaccination. 
In general, immunity includes a rapid and strong agglutinating response. 
The duration of immunity is lifelong and is serovar-specific . Although 
cell-mediated immune responses are involved, immunity to leptospirosis is 
primarily humorally mediated and antibodies involved in opsonization a nd 
agglutination of leptospires are of prime importance (l - 7). Current 
L. interrogans vaccines composed of heat-killed or chemical l y inactivated 
bacteria can protect animals against many signs o f leptospirosis (7 - 10). 
The National Veterinary Services Laboratories (NVSL) are responsible 
for the laboratory support and licensing of vaccines of viral and bacterial 
origin as well as veterinary diagnostic kits and reagents. Efficacy, 
potency, and safety testing of vaccines and bactcrins are important 
components of pre-l icense assessment as well as quality control of each 
serial (lot) of product produced. These procedures are well established 
for veterinary biologicals . 
The current testing of leptospiral bacterins licensed by the United 
States Department of Agriculture requires a hamster potency assay (11) . 
The hamster potency assay involves vaccinating hamsters with a specified 
dilution of the bacterin. Two weeks post- vaccination, hamsters are 
challenged with liver homogenates from the appropriate ser ovar- infected 
hamster and the percent survival is determined . There is a need to replace 
the in vivo assay with a rapid, sensitive, and reliable alternate in vitro 
method that could be used in the routine testing of leptospiral 
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biologicals. The large number of hamsters required for the manufacture and 
testing of these biologicals is expensive, and increasing concern for 
animal welfare and human health makes in vitro assays desirable. An 
enzyme-linked immunoassay (ELISA) would be simple, safe , easily automated, 
inexpensive, and suitable for potency testing of large numbers of product 
serials. The NVSL has recently reported on the development of an ELISA 
test for measuring the relative potency of leptospiral bac t e rins containing 
serovar p omona (12). The objective of this study was to develop a similar 
assay for measuring the relative potency of leptospiral bacterins 
containing serovar canicola. 
Bacterial Strains 
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MATERIALS AND METHODS 
Materials 
Leptospira interrogans strains used in this study were obtained from 
the National Veterinary Services Laboratories (NVSL) collection. Strains 
virulent for hamsters included L. pomona 11000 (MLS), L . hardjo 11601 
(SC1769) , L. grippotyphosa 11808 (Oregon shrew), L. canicola 11203 
(Moulton), and L. icterohaemorrhagiae 11403 (CFl). Leptospira bratislava 
2a and L . bratislava jez were also us~d . Serovars within t~e Serogroup 
canicola used in this study included banfani (strain banfani), benjamin 
(strain benjarnin), bindjei (strain bindjei) , broomi (strain patone), 
canicola (strain Hand U IV), galtoni (strain 1014), jonsis (strain jones), 
kamituga (strain kamituga), malaya (strain H6), portlandvere (strain 63-
69), schueffneri (strain vleermuis), and sumneri (strain sumner). Unless 
indicated, all organisms were heat inactivated by incubation in a 56° c 
water bath for 30 min . 
Bacterins 
Bacterins used in the antigen extinctio n studies and tested by the 
ELISA included lic.2nsed commercial adjuvanted and n0n-adjuvanted bacterins . 
The NVSL reference L. canicola bacterin was also used. The test reference 
bacterin for the ELISA was a non-adjuvanted bacterin containing 
approximately 4. 7 x 109 organisms per ml using a Petroff-Houser counting 
chamber. In order to determine whether the L. canicola ELISA would detect 
an unsatisfactory bacterin, ten serial two-fold dilutions of the NVSL 
reference L. canicola bacterin (beginning with 1:3) were prepared in PBS 
(pH 7.2). These dilutions were then used to vaccinate hamsters (5 
hamsters per dilution) and challenged two weeks later according to the Code 
of Federal Regulations (11). These dilutions were also evaluated in the 
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L. canicola ELISA. 
The specificity of the ELISA was evaluated using preparations 
containing no L. canicola organisms (heterologous) as well as those 
containing L. canicola organisms (homologous). Heterologous commercial 
licensed bacterins evaluated include: Pasteurella Haemolytica, Escherichia 
coli, Leptospira Hardjo-Icterohaemorrhagiae-Pomnona, Salmonella 
Cho leraesuis, Campylobacter Fetus, Actinobacillus Pleuropneumoniae-
Haemophilus Parasuis-Pasteurella Multocida, and Actinobacillus 
Pleuropneumoniae. Homologous commercial licensed bacterins evaluated 
include: Parvovirus-Erysipelothr ix Rhusiopath iae-Leptospira Canicola-
Grippotyphosa-Icterohaemorrhagiae-Ha rd jo-Pomona , Trichomonas Fetus-
Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-
Hardjo-Pomona, Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-
Icterohaemorrhagiae-Hardj o-Pomona , and the NVSL L. canicola reference 
bacterin. Inactivated whole cel ls evaluated by the ELISA include: 
Leptospira serovars grippo typhusa, pomona, icterohaemorrhagiae, and hardjo, 
Bordetella bronchiseptica, S almonella typhimurium, Salmonella choleraesuis, 
Escherichia coli, and Pasteur ella mul t ocida type D. 
Animals 
Eight- t o nine-pound New Zealand white rabbits (Harlan-Sprague-
Dawley, Inc., Indianapolis, IN) we re used to prepare serovar-specific 
antisera . 
Fifteen- to twenty-gram male BALB/c mice (Harlan- Sprague- Dawley Inc . , 
Indianapo lis, IN) were used for the monoclona l antibody (MAb) production. 
Antigen extinction studies were performed in 40- to 50-gram golden Syrian 
hamsters (Sasco, Inc., Omaha, NEj . Correlation with in vivo studies was 
performed in 40- to 50-g golden Syrian hamsters (Sasco, Inc., Omaha, NE). 
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Antisera Production 
A hamster virulent culture of L. canicola was used to inoculate each 
of two tubes (1 ml each) of semi-solid P80-BA medium (13). The tubes were 
then incubated at 37° C for 21 days. Sterility of t he culture was 
determined by inculating t wo 5% bovine blood agar plates, two tubes of 
fluid thioglycolate, and t wo tubes of trypticase soy broth with 200 µl of 
the culture. One set of each inoculated media were incubated at room 
temperature (27° C) and one set at 37° c f or seven days. 
Two rabbits were inoculated with 1.0, 2 . 0, and 4.0 ml of the P80-BA 
semi- solid culture. A fourth inoculation of 4.0 ml was given to each 
rabbit 7 days after the last 5-aay inter val inoculation. The first three 
vaccinations consisted of heat-inactivated cultures that were prepared by 
incubating the inocula in a 56° C water bath for 25 min. The last 
vaccination consisted of viable cultures. All inoculations were given 
intravenously in the marginal ear vein. After the final inoculation, the 
rabbits were observed for 10 days. On the tenth day, blood was obtained by 
cardiac puncture and the serum harvested by centrifugation at 3,000 x g for 
15 min. The antibody titer o f the serum was determined by the microscopic 
agglutination test (MAT) as described below. A titer of 1:1600 was 
considered to be satisfactory. The serum was filtered with a 0.22 µm 
filter (Millipore Corp., Bedford , MA) and stored at -70° c in 2-ml 
aliquots . 
Methods 
Ant i gen Extraction 
Leptospira interrogans organisms were grown in 1 L P80 liquid media 
(13) for 7 days at 30° c. Cultures of the Moulton strain o f L. canicola 
harvested after 7 days incubation contained approximately 1 x 106 
leptospires/ml. The organisms were harvested by c entrifugation (12,000 X g 
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for 30 minutes) and were washed three times in PBS (pH 7.2). Pellets were 
resuspended in 6 ml of a tris-tricine, 5 mM ethylenediaminetetraacetic acid 
(EOTA) solution (pH 8.6) containing 0.01% Triton X-100. Suspensions were 
incubated overnight on a pl atform r ocker at r oom t emperature and then 
centrifuged as before. Supernatants containing the outer envelope antigens 
were filter sterilized and stored at 4° C until usEd to ~mmunize BALB/c 
mice for the production of the 408 MAb. Total protein was determined by 
the SCA method (Pierce Chemica l Co ., Rockford, Il). 
Monoclonal Antibody Production 
The MAb 408 was produced by the method of Van Oeusen and Whet stone 
(14) using the Triton X-100 extract of the NVSL challenge strain (Moulton) 
of L. canicola. BALB/c mice were in jected intraperitoneally (ip) with 
nonadjuvanted Triton X-100 extract of serovar canicola containing 
approximately 50 µg of protein. A 50 - µg booster i njection was given 
intravenously 3 weeks later. Selection of clones was based on a) high 
ELISA op tical density (OD) values (e.g., ~ 0.400) wi th the homologous 
antigen and no cross-reactivity wit h heterologous antigens, and b) passive 
protection studies in hamsters. 
used to prepare ascite s fluid . 
The selected c l o ne, designated 4DB, was 
The ant i body isotype of the 4DB MAb was 
determined to be IgM using a Mouse Typer Sub-Isotype Kit (Bio-Rad 
Laboratories, Richmond, CA). The total antibody concentration in the 
ascites fluid was determined to be 275 mg/ml using a radial immunodiffusion 
(Calbiochem, San Diego, CA ). 
Microscopic Agglutinatio n Test 
The MAT was performed according to established protocols (15) . 
Briefly, serial 2-fold dilutions (begining with 1 :25) o f the 408 MAb were 
incubated with viable serovars canicola , grippotyphosa , har djo , 
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icterohaemorrhagiae, pomona, and bratislava. The foll owing serovars of the 
Serogroup canicola also served as antigen: banfani (st rain banfani), 
benjamin (strain benj amin), bindjei (strain bindjei), broomi (strain 
patone), canicola (strain Hond U IV), galtoni (strain 10 14), jonsis (strain 
jones), kamituga (strain kamituga ), malaya (strain H6), portlandvere 
(strain 63-69), schueffneri (strain vleermuis), and sumneri (strain 
sumner). The ability of the 40B MAb t o agglutinate viable cells was 
assessed. 
Passive Protection Studies 
Four groups of five hamsters each were injected ip with 0.5 ml of 
undiluted hybridoma cu lture fluid containing the 40B MAb . Five non-
vaccinated control hamsters r eceived an equal antibody c oncentration of 
ascites fluid prepared against Pasteurella mul t ocida type 0 dermonecrotic 
toxin (NVSL). Both groups of hamsters were challenged 24 h later with 0 . 25 
ml of liver suspensions fr om hamsters infected with serovars canicola, 
icterohaemorrhagiae, grippo typhosa , and pomona (10 t o 10 , 000 LO~'s as 
determined by titration (11)). Results we r e recorded as the number of 
survivo rs per total number of animals chal l enged . 
SOS-PAGE 
Heat-inactivated whole cells of serovars canicola , grippotyphosa , 
hardjo , icterohaemorrhagiae , and pomona as wel l as the Triton X-100 extract 
of serovar canicola were u sed foL SOS-PAGE analysis. The samples were 
separated on a 14% polyacrylamide gel with a 4% stacking gel using a 
Profile System (Schleicher & Schuell , Keene, NH). Antigens were treated 
with sample buffer containing 0 . 05% 2- mercaptoethanol and 2% SOS . Samples 
were boiled for 5 min at 100° C prior to electrophoresis at 30 mA p e r gel 
for 1.5 h. Gels were eithe r stained f or protein with Commassie Brilliant 
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Blue (G-250), or stained for lipopolysaccharide with a mod ified silver 
stain. 
Silver Stain for Lipopolysaccharide ILPS) 
Polyacrylamide gels were stained for LPS using a modifed silver stain 
(16). Briefly, LPS in the gels was oxidized wi t hout prior fixation with a 
0.7% (w.v) periodic acid in 40% ethanol and 5% acetic acid for 20 min at 
22° c. After three washes (S mln each~ in distilled water, the gels were 
incubated in fresh staining solution f or 10 min at 22° c. The staining 
solution was prepared by add i ng 4 ml o f concentrated ammonium hydroxide 
(29.4%) to 56 ml of a 0.1 M sodium hydroxide s o lutio n . After add i ng 200 ml 
of distilled water, 10 ml of a 20% (w.v) s o lutio n of silver nitrate (in 
distilled water) was added dropwise while stirring. After washing the gel 
three times (5 min each) with distilled water, the color development 
solution was added. The color development solution was prepared by adding 
0.1 ml of a 37% formaldehyde solution to 200 ml of distilled water 
containing 10 mg of citric acid. The c o l or development was allowed to 
proceed for approximately 10 min a t 22° c. The color development solution 
was decanted and the reacticr. we~ stopped by adding 10% acetic acid (in 
distilled water) for 1 min follo wed by several washings in distilled water. 
Western Blotting 
After frac tionation, gel-bound antigens were e lectro-transfered to 
nitrocellulose membranes (Mill ipore Inc., Bedford, MA) a t 125 mA for 2.5 h . 
Electro-transfer was carried out in buffer containing 12 mM tris and 96 mM 
glycine (pH 8.3). After transfer , the membrane was incubated in PBS 
(pH 7 . 2) containing 0.15% Twee n 20 (PBST) for 10 min followed by rinsing in 
distilled water for 1 min. The membrane was the n incubated in 20 ml of a 
1:100 dilution (in PBST containing 1% normal r abbit s era ) of 4DB ascite s 
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fluid for 1 h at 37° c. After rinsing in distilled water , the membrane was 
incubated in a 1:2000 dilution (in PSST containing 1% normal rabbit sera) 
of goat anti- mouse I gM peroxidase-labeled antibody co~jugate (Kirkegaard & 
Perry Laboratories, Inc., Gaithersburg, MD) for 1 hat 37° c . The membrane 
was washed in PSST for 2 min followed by incubation in color development 
solution for 10-15 min. The color development solution consisted of two 
solutions (A & B) that were mixed prior to use. Solution A contained 75 mg 
of 4-chloronaphthol dissolved in 25 ml of cold methanol. Solution B 
consisted of 125 ml tris-buffered saline (TBS) containing 76 µl of 37% 
hydrogen peroxide (Fisher Scientific, Fair Lawn , NJ). 
Biochemical Determination of Epitope by Proteinase K Digestion 
In this experiment, heat-inact ivated whole cells o f serovars 
canicola , grippoty~hosa, icterohaemorrhagiae, and p0mona (50 µg protein 
each) were treated with proteinase K prior to electropho resis. Paired non-
treated samples were also used. Samples were separated into 2 identical 8-
16% gradient gels with a 4% stacking gel (Schleicher & Schuell, Keene, NH) . 
After electrophoresis, one gel was stained with Coomassie Brilliant Blue 
for protein. Antigens contained in the second gel were electro- transfered 
to nitrocellulose membrane and then probed with the 4DB ascites fluid as 
previously described. Proteinase K-treated samples were also tested in the 
L. canicola ELISA protocol (Phase II). 
ELISA Protocol 
Reagents 
Horseradish peroxidase (HRP) labeled goat anti-mouse IgM conjugate 
and 2 ,2 '-azino- di-3-ethylbenzthiazoline sulfonate (ABTS) (Kirkegaard-Perry 
Laboratories, Inc., Gaithersburg, MD) were used as the antibody conjugate 
and substrate , respectively. Polyvinyl alcohol (PVA) was obtained from 
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Aldrich Chemical co., Inc, Milwaukee , WI. Polyclonal rabbit antisera 
prepared against L. canicola was produced at the NVSL. Immunlon- 2 
microtitration plates were obtained from Dynatech Laboratories, Inc., 
Alexandria , VA. 
The capture antiserum was diluted in coating buffer (0 . 05 M carbonate 
buffer, pH 9.6) containing 1.59 g Na2C03 and 2.93 g NaHC03 per liter of 
distilled water. The antigen (bacterin) diluent was filter sterilized 
phosphate buffered saline (PBS) (0.15 M, pH 7.2) containing 8.0 g NaCl, 0.2 
g KCl, 1.15 g Na2HP04 , and 0.2 g KH2P04 per liter o f distilled water . The 
blocking solution consisted of a 1% solution of PVA (MW 13,000) in antigen 
diluent. Antibodies were diluted in blocking solution supplemented with 1% 
normal rabbit serum . 
Antigen Elution Procedure 
Only bacterins that were adjuvanted with aluminum hydroxide or oil 
(and their derivatives) required elution treatment prior to use in the 
ELISA protocol . Bacterins containing adjuvants other than aluminum 
hydroxide or oil (and their derivatives) required no treatment prior to use 
i n the ELISA protocol. As an adjuvant control, an aluminum hydroxide 
solution (2% Al20 3 ) was diluted to correspond to the final concentration 
contained in the product bein~ t~sted . Seriai two-fold dilut i o ns of the 
adjuvant control (begining with 1:4) was used in the ELISA protocol. 
Sodium citrate and potassium phosphate antigen elution methods were 
evaluated for removing antigen from aluminum hydroxide adjuvants . The 
sodium citrate elution method consisted of adding 1 ml of the bacterin to 
0 .171 g of sodium citrate crystals (Fisher scientific, Fair Lawn , NJ) and 
incubating overnight (16-20 h) at 37° Con an orbital shaker (120 RPM). 
The treated bacterin was used in the ELISA protocol without centrifugation. 
The potassium phosphate elution buffer was prepared by dissolving 8 . 2 g of 
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KH2PO, (Mallinckrodt , Inc., Paris KY) in 94 ml distilled water. After the 
pH was adjusted to 7.25, 1 .55 ml of bacterin and 0 .45 ml of buffer were 
mixed together and incubated overnight at 37° c on an orbital shaker (120 
RPM) , the samples were used in t he ELISA protocol. 
Two antigen- elution met:hods were evaluat:ed for r emoving antigen from 
bacteri ns containing oil as an adjuvant. One method was a sodium 
desoxycholate buffer which was prepared by dissolving 0.50 g of sodium 
desoxycholate (Difeo Laboratories, Detroit , MI) in PBS (pH 7.2) . Equal 
amounts of buffer and bacterin were incubated overni ght at 22° C. The 
mixture was centrifuged (10,000 x g) f o r 5 min, and the aqueous phase below 
the oil layer was aspirated with a tubercu l in syringe by insertion of the 
needle through the tube. The aqueous phase was used in the ELISA protocol. 
The second ant igen elutio n method involved incubation of the bacterin with 
a 0 . 5% (w/v) solutio n of sodium dodecylsu lfate (SOS) (Biorad Laboratories, 
Richmond, CA). The buffer was prepared by dissolving 0.5 g of SOS i n 
100 ml distilled water. One-anrl-one-half milliliter s o! ba=terin was added 
to 0.5 ml of buffer and incubated overnight at 22° C on a rotary shaker at 
120 RPM followed by centrifugatio n ( 10 ,000 x g ) for 10 min. The aqueous 
phase immediately beneath t he oi l layer was removed with a tuberculin 
syringe as previously described. This phase was used in the ELISA 
protocol. Serial two-fold dilutions of a commercial oil adjuvant were also 
used as an adjuvant control. 
Bacterins containing a combin ation of adjuvants such as aluminum 
hydroxide and oil, either a lone or in combination with other adjuvants, 
required adding 1.5 ml of t he bacterin to 0 . 5 ml of the potassium phosphate 
(pH 7.25) and 0.5 ml of the 0 . 5% SOS solution. The mixture was incubated 
at room temperature (22° C) overnioht on a rotary £h~ker (120 RPM). After 
centrifugation (10,000 x g) , the aqueous phase was removed a s previously 
described. This phase was used in the ELISA protocol . 
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ELISA Procedure 
The ELISA procedure consisted of two phases. In phase I, a 1 : 20 
dilution (in PBS) of the bacterin was made and used in the ELISA protocol . 
Bacterins that did not pass in phase I are then evaluated in phase II in 
which the bacterins were not diluted prior to use in the ELISA protocol . 
Polyc l onal hyperimmune rabbit antiserum (prepared against 
L. canicola) was diluted 1:100 in coating buffer (pH 9.6) . All wells of an 
Immulon- 2 microtitration plate were coated with 100 µl of the diluted 
rabbit antisera prepared against L. canicola , and the plate was incubated 
at 4° C overnight (16 - 20 h). Bacterins containing aluminum hydroxide o r 
oil (and their derivat ives) as an adjuvant were t~eated as previously 
described . A non-adjuvanted L. canicola bacterin served as the test 
reference and was not pre-treated. Non-adj u vanted bacterins and bacterins 
containing adjuvants other than aluminum hydroxide or oil were assayed 
without prior elution treatment. 
The reference bacterin was a non- adjuvanted bacterin containing 
approximately 4.7 x 109 organisms per ml . The ELISA dilutions of the 
reference bacterin were 1:50, 1:100, 1;150, 1: 250 , and 1:500 diluted in 
10 ml of PBST for 1-, 2-, 3-, 5-, and 10- ml dose p roducts, respectively, 
regardless of the adjuvant contained in the product. These dilutions were 
considered to be undiluted and were used in the ELISA protocol without 
prior diluting. The pre-diluted test reference, the treated bacterins , and 
all other bacterins (non-adjuvanted and those not containing aluminum 
hydroxide or oil) are assayed at serial 2-fold dilutions (in PBST) 
beginning with a 1 :2 dilution. All dilutions were made in a Falcon 96-well 
transfer plate (Becton Dickinson and Co. , Lincoln Park, NJ). 
Following aspiration of the capture polyclonal sera, 250 µl of the 
PVA blocking solution was added to all wel ls, and the plate was incubated 
for 1 h at 37° C on an orbital shaker. The plate was washed once with 
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PSST (PBS containing 0.05% Tween 20, pH 7.2 ), and 100 µl of each dilution 
of the bacterins and the test reference was transfered to duplicate wells 
beginning with the highes t dilutio n . The plate was incubated for 1.5 h at 
37° C on an orbital shaker. After washing five times with PSST, 100 µl of 
a 1:14,000 dilution of the 408 ascites fluid was added to all wells, and 
the plate was incubated at 37° C for 1 h. After the plate was washed four 
times to remove unbound 4DB MAb, 100 µl of a 1 :2000 dilution of goat anti-
mouse IgM(µ) peroxidase labeled antibody conjugate was added to all wells, 
and the plate was incubated f or 1 h at 37° c. After f our washes , 100 µl of 
ABTS was added to all wells, and the plate was sealed and incubated for 30 
min at 37° con an orbital shaker (120 RPM). The color reactio n was 
stopped with an equal volume of 10% sos. The pla te was read at a dual 
absorbance of 405/490 nm (Vmax Microtiter Reader, Mo lecular Devices, Inc. , 
Menlo Park, CA). 
Data Analysis 
The mean OD for all blank wel l s was determined , and that value was 
subtracted from all sample OD values prior t o data ana lysis. Linear 
regression and relative potency (RP ) were calculated according to the NVSL 
RelPot computer program (version 3 .0) . This prog r am is designed to assign 
weight to linea r regression lines for both a reference and a test sample. 
Slopes were checked f o r parallelism, and the relative potency calculations 
were made. Criteria for a valid test were : a) a simple line ar regress ion 
line must be fitted to a minimum of three contiguous dilutions, and b) 
l ines must have a correlation coefficient (r) of at least 0 . 95. For more 
i nformat ion and availability of the RelPot Program, interested persons may 
contact the National Veterinary Services Laboratories , Ames, Iowa 50010, 
USA. 
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In vitro vs In Vivo Correlat ion Study 
Ten serial two-fold ciluti o~s (beginn i n9 with 1:3~ of the NVSL 
reference L. canicola bacterin were prepar ed and used to vaccinate hamsters 
by intramuscular injection. These preparations were considered to be 
undiluted and were diluted to l/80th o f the host anima l dose according to 
established protocols (11). The NVSL r eference L. canicola bacterin was 
also evaluated without prior dilution. There were 5 h amsters per bacterin 
dilution as well as 10 non-vaccinated control hamsters. Two weeks later, 
hamsters were challenged (ip) with 0 .2 5 ml o f liver homogenates from 
canicola- infected hamsters (10 to 10,000 LO~~ as determined by titration 
(11)). Results were recor ded as the percent o f survivors per t otal number 
of animals challenged. 
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RESULTS 
A Triton X- 100 extract of the NVSL challeng e strain o f serovar 
canicola was used to prepare hybridomas secreting monoclonal antibodies. 
The selected twice-cloned hybridoma , designated as 4DB , was shown to 
secrete IgM antibody and was shown to react with an epitope present on 
three moieties of 30, 20 , and 15 kDa in the Triton X- 100 extract and 
inactivated whole cells by western blot analysis (Figure 1) . The 408 MAb 
did not detect antigen in whole cell preparations of the he terologous 
serovar s. 
When inactivated whole cells were treated with proteinase K prior to 
SOS-PAGE, protein digestion appeared to be complete as demonstrated by the 
lack of staining by Coomassie Brilliant Blue (Figure 2). When these 
samples were transferred to nitrocellulose membranes, the 408 MAbs detected 
the same epitope on the three major moieties, as well as o ther minor LPS-
like moieties (Figure 3). The additiona l bands detected by the 408 MAb in 
Figure 3 were very similar, if not ide ntical, to t he epitope present on the 
LPS-like moieties that may have been masked by protein . Following 
proteinase digestio n, these epitopes became available to bind to the 408 
MAb. The presence of mo re than one LPS-like moieties , (containing the 408 
epitope), detected by the MAb ffiay be relateo to the growth phase o f the 
organism at the time of antigen extraction . It is possible that the 
culture that was used f o r antigen ext r action and heat-inactivation may have 
contained more than one population of canicola cells. One population may 
have p redominantly expressed the 408 epitope on a 30 kDa LPS-like mo iety, 
another population may have predominantly expressed the epitope o n a 20 kDa 
moiety, etc. When proteinase K- treated and non-treated samples of serovar 
canicola were evaluated by t he ELISA, the OD values were slightly higher as 
compared with the OD values of nontreated samples (data not shown) . The 
same three major moieties , (containing t he 408 epitope ), were also stained 
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with an LPS silver stain using proteinase K-treated and non-treated 
inactivated whole cells and the Triton X-100 extract (Figure 4). Based on 
these results, it is speculated that the 40B binds to an epitope contained 
within LPS-like moieties. This is advantageous for testing bacterin 
potency since LPS-like antigens have been shown to be responsible for the 
reaction in the agglutinating MAT and are involved in the protective 
humeral response to leptospiral infection (2 - 6). 
Results from MAT studies indicate that the 40B MAb agglutinated 
serovar canicola but failed to agglutinate heterologous L. interrogans 
serovars (Table 1). When 12 Canicola serovars were evaluated by MAT, only 
canicola serovars bafani, broomi, and portlandvere as well as canicola 
strain Hand U IV were agglutinated by the 408 MAb (Table 2). When tested 
by ELISA, the 40B MAb detected antigen in serovars bafani, bindjei, jonsis, 
and portlandvere as well as the canicola strain Hand U IV, but failed to 
detect significant amounts of anttgen in th~ remaining sernvars (Figure 5). 
The Moulton strain of serovar canicola was also evaluated, and results were 
comparable to the Hand U IV and portlandvere strains (data not shown) . 
Because most leptospiral biologicals manufactured in the United States 
contain either the serovar portlandvere or the canicola strains Hand U IV 
or Moulton, it is not important that the 408 MAb failed to detect other 
serovar strains within the Serogroup of canicola . No cross-reactivities 
were observed among serovars grippotyphosa, icterohaemorrhagiae , hardjo , or 
bratislava (Figure 6). In the hamster protection studies, the 408 provided 
passive protection against a homologous challenge; none of the hamsters 
were protected from heterologous challenges (Table 3). 
Results from specificity studies indicated th~t the ELISA is specific 
for Leptospira interrogans serovar canicola (Tables 4 & 5). The 408 MAb 
failed to detect antigen in members of other bacterial genera or in 
heterologous leptospiral serovars . Antigen was detected in all 
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preparations that contained serovar canicola (data not shown). 
Results from initial ELISA studies using the 408 ascites fluid 
indicated that non-adjuvanted bacterins and those containing adjuvants 
other than aluminum hydroxide or oil did not require antigen elution 
treatment prior to use in the ELISA protocol . Bacterins containing 
aluminum hydroxide as an adjuvant required treatment to elute antigen prior 
to use in the ELISA p r otocol. Although the nontreated bacterin resulted in 
higher OD values, a portion of these values was attributable to the effect 
of the aluminum hyrdoxide. Therefore, products adjuvanted with aluminum 
hydroxide required treatment to elute antigen form the adjuvant. A 
potassium phosphate buffer yielded optimal OD readings. Figure 7 shows 
ELISA results of a non-treated aluminum hydroxide-adjuvanted product and 
the same product treated with either sodium citrate or potassium phosphate. 
Pre-treatment with sodium citrate yielded OD values that were comparable 
to blank wells . Only the potassium phosphate treatment yielded 
satisfactory OD values. ELISA results also indicated that bacterins 
containing oil as an adjuvant required treatment to elute antigen prior to 
use in the ELISA protocol. Two antigen elution methods were evaluated. 
Treatment with a 0.5% SOS solution dramatically increased the OD values. 
Figure 8 shows ELISA results using a non-treated oi l-ad juvanted bacterin 
and the same bacterin treated with either a 0 . 5% SOS solution or sodium 
desoxycholate. The adjuvant control was also evaluated. A 0.5% SOS 
solution yielded optimal OD values as c ompared to the use of sodium 
desoxycholate as an antigen elution buffer. Wells containing the adjuvant 
control resulted in OD values comparable to blank wells. Although sodium 
desoxycholate treatment resulted in OD values comparable to the non-treated 
bacterin, these values were considered to be too low for use in calculation 
of relative potency of the bacterins. 
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A total of 185 leptospiral bacter ins representing 1-, 2-, 3-, 5-, and 
10-ml dose products (Table 6) were evaluated by the ELISA (Table 7). All 
bacterins evaluated by this system have met the minimum requirement of a 
relative potency of 1.0 or greater . 
Results of the in vitro and i n vivo correlation study indicated that 
the ELISA approximates the sensitivity o f t he hamster potency assay 
(Table 8) . When serial two-fold dilutions of the NVSL reference 
L . canicola bacterin were used to vaccinate hamsters according to 
established protocols (11), a dilution o f 1 :24 (l.823 x 106 organisms) 
provided 80% protection, whereas a 1:48 di lution (9 .11 5 x 105 organisms ) 
provided only 40% protection against a vi rulent cha llenge. When these 
bacterin dilutions were evaluated by the ELISA {phase II), t he 1: 48 
dilution (4.380 x 106 organi sms) resulted in an RP of 1 .08, whereas the 
1:96 dilution (2.190 x 106 organisms) r esult ed in an RP of 0.61. The 1 :24 
dilution used to vaccinate hamsters contained 83% of the organisms (1.823 x 
106 ) used in the ELISA and provided 80% protectiun. 
Figure 1 . Western blot using the ascites fluid containing the 408 MAb to 
de tect antigen in the Triton X-100 extract of serovar canicola a nd 
inactivated whol e cells o f serovars canicola, icterohaemorrhagiae, hardjo, 
grippotyphosa, and pomona . Sampl es were standardized to 50 µg of protein 
per lane . After eletro-transfer, the membrane was incubated in a 1:100 
dilution of the 408 ascites fluid followed by incubation in a 1:2000 
dilution o f ho rseradish peroxidase-conjugated anti-mouse IgM . The 
substrate was 4-chloro naphthol . Lane 1: L. pomona whole cells, Lane 2 : 
L. grippotyphosa whole cells , Lane 3 L. hardjo whole cells, Lane 4: 
L . icterohaemorrhagiae whole cel l s , Lane 5 : L . canicola whole cells , Lane 
6: Triton X-100 extract of L. can icola, Lane 7 : L . bratislava whole cel ls, 
Lanes 8 & 9: blank, Lane 10: pre-stained low mo l ecul ar mass markers . 
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Figure 2. Coomassie Brilliant Blue stained SOS-PAGE gel containing boiled 
Triton X-100 extracts and boiled inactivated whole cells of serovars 
canicola and pomona. Samples were standardized to 50 µg of protein per 
lane and were either treated or not treated with proteinase K prior to 
electrophoresis into a 4-20% acrylamide gradient gel. Lanes 1&6: L. pomona 
inactivated whole cells, Lanes 2&7: L. pomona Triton X-100 extract, Lanes 
3&8: L. canicola inactivated whole cells, Lanes 4&9: L. canicola Triton X-
100 extract, Lane 5: pre-stained low molecular mass markers. Samples in 
lanes 1-4 were not treated with proteinase K. Lanes 6-9 were identical to 
lanes 1-4 except that these samples were treated with proteinase K. 
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Figure 3 . Western blot using boiled inactivated whole cells of serovars 
canicola, grippotyphosa, icterohaemorrhagiae, and pomona. The boi l ed 
Triton X-100 extract of serovar canicola was also used. Samples wer e 
standardized to contain 50 µg of protein per lane and were either t r eated 
or not treated with proteinase K prior to electrophoresis i n to a 4 - 20% SOS 
gradient gel. Lanes 1&6: L. grippotyphosa inactivated whole cells , La nes 
2&7 : L . icterohaemorrhagiae inactivated whole ce l ls , Lanes 3&8 : L . canicol a 
inactivated whole cells, Lanes 4&9: L. canicola Triton X- 100 extract , Lane 
5: pre-stained low molecular mass markers. Lanes 1- 4 were treated with 
proteinase K. Lanes 6-9 were not treated with proteinase K. 
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Figure 4. A 14% sos gel containing the Triton X-100 and i nactivated who le 
cell s of serovar canicola. Both samples were boiled prior to 
electrophoresis. The gel is stained for lipopol ysaccharide using a modifed 
s ilver stain. The samples were s tandardized to contain 50 µg of protein 
per l ane. Lane 1: pre- stained low molecular mass markers , Lane 2 : 
L. canicola Triton X-100 extract, Lane 3: L . canicola inactivated whole 
cells . 
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Table 1. Microagglutination titers 
o f the 408 MAb f or var-
) .(;U:3 aercvc.rs of 
L. interrogans 
Antigen• MAT Titer6 
Pomona <20 
Canicol a 10240 
Grippotyphosa <20 
I cterohaemorrhagiae <20 
Hardjo <20 
Bratislava 2a <20 
Bratisl ava jez <20 
• 
b 
Viable whole cells of h ams ter 
virulent serovars of L . interrogans 
were used as the antigen. 
Titer is expressed as the average 
r eciprocal dilutio n at which 50% of 
the leptospires were agglutinated . 
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Table 2 . Specificity of the 408 MAb among canicola 
serovars by the microagglutination test (MAT) 
An t igena MAT Tit er 
L. 
L . 
L . 
L. 
L. 
L . 
L . 
L . 
L . 
L. 
L. 
L. 
a 
canicola bafani bafani 2560 
canicola benjamin benjamin <20 
canicola bindjei bindjei <20 
canicola s chueffneri vleermuis <20 
canicola sumneri sumner <20 
canicola broomi pa tone 1 53 60 
canicola canicola Hond u IV 20480 
canicola galtoni 1014 <20 
canicola j onsis jones 80 
canicola kamituga kamituga 960 
canicola mal aya H6 <20 
canicola portlandvere 63-69 20480 
Viable whole cells of each serovar were used as the 
antigen. 
Titer is expressed as the a verage reciprocal dilu-
tion at which 50% of the l ept ospires were agglutin-
ated . 
Figure 5. ELISA results using the 408 ascites fluid to detect 12 canicola 
serovars. Heat-inactivated whole cells were diluted 1:128 and captured by 
the polyclonal anti-canicola rabbit serum. A 1:14,000 dilution of the 408 
ascites fluid was added followed by a 1:2,000 dilution of horseradish 
peroxidase-conjugated goat anti-mouse IgM. The substrate was ABTS. 
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Figure 6 . ELISA results using the 408 ascites fluid to detect six 
inactivated whole cells of Leptospira interrogans serovars . Inactivated 
whole cells were diluted 1:128 and captured by the polyclonal anti- canicola 
rabbit serum. A 1:14,000 dilution of the 408 ascites fluid was added 
followed by a 1 :2000 di l ution of horseradish peroxidase-conju gated goat 
anti-mouse IgM. The substrate was ABTS. 
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Table 3. Passive protection of hamsters with the 40B MAb against a virulent 
challenge of serovars canicola, icterohaemorrhagiae, 
grippotyphosa, and pomona• 
Vaccination 
Material 
Hamsters Surviving 
Homologous Challenge 
(L . canicola) 
Hamsters Surviving 
Heterologous Cballengeb 
(I) (G) (P) 
40B MAb c 0/5 
0/5 
0/5 
0/5 
0/5 
0/5 Controls (ONT MAb) • 0/5 
a 
b 
Control hamsters were passively immunized with an equal antibody 
concentration of ascites fluid prepared against the dermonecrotic toxin 
of P. multocida Type 0. Hamsters were vaccinated with the 408 MAb and 
challenged 24 h later with virulent organisms. 
Heterologous L. interrogans serovars Icterohaemorrhagiae (I), 
Grippotyphosa (G), and Pomona (P). 
The 40B ascites fluid contained 275 mg of IgM per milliliter. 
Results expressed as survivors per total animals challenged. 
• The volume of ONT ascites fluid contained 275 mg of IgG1 per milliliter. 
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Table 4. Preparations used to determine the 
specificity of the L. canicola ELISA• 
PreQaration6 Adjuvant< ELISA OD 
Le NA 1. 786 
Ph Al OH + Quil A 0 . 022 
Ee Al OH 0 . 040 
LHIP Al OH 0 . 0 11 
Schol Al OH 0 . 021 
Cf Al OH 0.045 
App, Hpara, Pm Al OH 0 . 035 
App Oil 0.002 
• 
b 
Preparations containing no L. canicola 
organisms were used as we l l as the ELISA 
test referenc e bacterin as a positive control. 
Optical density values represent a 1 : 2 dilution . 
Commercial licensed bacterins containing no 
L . cani cola organisms . Le = ELISA test 
r e ference , Leptospira Canicola Bacterin ; 
Ph = Pasteurella Haemolytica Bacterin; Ee 
Escherichia Coli Bacterin ; LHIP = Leptospira 
Hardjo-Ictero haemorrhagaie-Pomona Bacterin ; 
Schol = Salmo nella Choleraesuis Bacterin; 
Cf = Campyloba c ter Fetus Bacterin; APP, Hpara , 
Pm = Actinobac illus Pleuropneumo niae-Haemophilus 
Parasu is-Pasteurella Multocida Bacterin- Toxoid; 
App = Actinobacillus Pleuropneumo niae Bacterin . 
NA = non-adjuvanted; AlOH = aluminum hydroxide . 
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Table 5. I nactivated whole cells used 
to determine the specificity of the 
L. canicola ELISA" 
Organismb ELISA OD 
Le l. 883 
Lg 0. 010 
Li 0.031 
Lp 0.001 
Bb 0 . 062 
Pm 0. 031 
Schol 0.022 
a 
b 
Organisms evaluated included various 
L . interrogans serovars and heterologous 
bacteria. The ELISA test reference 
bacterin served as a positive control. 
Optical density values represent a 1:2 
dilution. 
Le = L. canicola ELISA test reference 
bacterin; Lg = Leptospira grippotyphosa; 
Li = Leptospira icterohaemorrhagiae; Lp = 
Leptospria pomona; Bb = Bordetella bronchi-
septica; Pm = Pasteurella multocida type D; 
Schol = Salmonella choleraes ui s . 
Figure 7. Results using the 408 MAb in the ELISA to detect antigen in a 
5-ml dose aluminum hydroxide-adjuvanted product. Two antigen elution 
methods were evaluated as well as evaluation of the bacterin without prior 
treatment. After antigen in the samples were captured, a 1:14,000 dilution 
of the 408 ascites fluid was added followed by a 1:2,000 dilution of 
horseradish peroxidase-conjugated goat anti-mouse IgM. The substrate was 
ABTS. TR: test reference , NT: not treated, Cit: sodium citrate, KH2P04 : 
potassium phosphate buffer. 
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Figu re 8 . Results using the 408 ascites fluid in the ELISA to detect 
antige n in a 5-ml dose oil- adjuvanted product. Two antigen elutio n methods 
were evaluated as well as evaluation of the bacterin without prior 
treatment . After antigen in the samples were captured, a 1 : 14,000 dilution 
of the 408 ascites fluid was added followed by a 1:2 , 000 di lution of 
horseradish peroxidase-conjugated goat a n ti-mouse IgM. The color substrate 
was ABTS . TR: test reference , NT: not treated, DOC : desoxycholate , SOS: 
sodium dodecyl su lfate . 
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Table 6 . Bacterins evaluated f o r relative p o tency by the L. canicola ELISA 
Total No. Host Animal No . Adjuvant in Product 
Products Dose Firms Al OH Oil Combination• Otherb None 
9 1-ml dose 2 5 4 
71 2-ml dose B 50 7 1 4 
17 3-ml dose 1 17 
86 5- ml do se 6 65 13 B 
2 10- ml d o se 1 2 
a Products c o ntaining a combi~ati0n o f adjuvant s. 
Products containing ad j uv a nts othe r tha n aluminum hyd roxide or o il . 
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Table 7. Representat ive ELISA results for phases I and II of 
the L . canicol a ELI SA u sing random leptospiral 
bacterins' 
Relative Potency Range 
Host Animal Dose Phase I Phase II 
1-ml dose 4.55 - 5.48 NAb 
2-ml dose 1. 14-9. 18 3.06- 4 .17 
3-ml dose 0.27-0.38 2.36-2.46c 
5-ml dose 2 . 34-4.21 4 .90-38 .20 
10-ml dose 2.04-2 . 08 NA 
Results are expressed as the range of highest relative potency 
c a lculation as determined by the NVSL RelPot c o mputer progr am. 
There were no products that required testing by phase II. 
All products of this host animal dose that were tested had 
passed in phase I . NA = no t applicable . 
These are products that failed in phase I and were re-tested 
in phase II. 
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Table 8. Comparison of hamster protection and the a bi l ity of the 
L. canicola ELISA to detect an unsatisfactory bacterin" 
Bacterin No. Organisms No. No. Organisms ELISA Resultsa 
Dilution Injected Survivorsb ReQresented• __ I_ II 
Undiluted 4.375 x 107 5/5 (100%) 1.051 x 107 7.01 
2 .102 x 108 12.31 
1:3 1. 458 x 107 5/5 (100%) 3.505 x 106 3.81 
7.009 x 107 5 . 11 
1:6 7.292 x 106 5/5 (100%) 1. 752 x 106 NVC 
3.504 x 107 3.31 
1:12 3.646 x 106 5 /5 (100%) 8.761 x 1 0 5 NVC 
1. 752 x 107 2.69 
1:24 1. 823 x 106 4 /5 (80%) 4 . 381 x 105 NVC 
8.762 x 106 1. 94 
1:48 9 .115 x 105 2/5 (4 0%) 2.190 x 105 NVC 
4.380 x 106 1. 08 
1:96 4.557 x 105 1 /5 (20 %) 1. 095 x 105 NVC 
2.190 x 106 0 . 61 
1:192 2.279 x 105 2/5 (40%) 5.476 Y- 104 NVC 
1. 095 x 1C6 NVC 
1:384 1.139 x 105 0/5 (0%) 2.738 x 104 NVC 
5.474 x 105 NVC 
1 :7 68 5.697 x 104 0/5 (0%) 1. 369 x 104 NVC 
2.737 x 105 NVC 
The NVSL reference L. canicola bacterin was diluted to 1/80th of a 
2-ml d ose and used to vaccinate hamsters f o llowed by a virulent 
b 
c 
d 
L. canicola challenge t wo weeks later. The same bacterin was 
evaluated against the ELISA test reference bacterin according t o the 
ELISA protocol without diluting to 1/80th of a 2 - ml dose 
Number of hamsters surv iving a virulent L. canicola challenge. 
Results are expressed as the number of survivors per total number of 
animals challenged. 
Number of organisms u sed in the ELISA at a 1:2 dilution . 
Results are expressed as the highes t RP values as determ i ned by the 
RelPot computer program. RP values for phase I are not adjusted for 
the 1:20 dilution. The uacter i n s were evaluated in b oth phases of 
the ELISA protocol. NVC, no valid combinations. 
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DISCUSSION 
Because of the increasing concern for reducing animal costs, 
improving animal welfare and human health risks, the d evelopment of an in 
vitro assay for measuring the relative potency of leptospiral bacterins 
containing serovar canicola was developed. This ELISA system was developed 
to address these concerns . 
A monoclonal antibody directed against surface antigens of the 
Moulton strain of serovar canicola was developed using a Triton X-100 
extract of this serovar. The selected hybridoma, 4D8, wa s shown to secrete 
IgM- type antibody that was shown to be protective, agglutinating, and 
serovar-specific. The 408 MAb ~ppedra tc react with an epitope present on 
LPS-like moieties of whole cells of the Mou lto n strain of serovar canicola 
(Figures 1-4). 
The MAT and ELISA results show that the 408 MAb is specific f o r 
Serogroup canicola. Agglut ination occured with on ly the Serogroup canicola 
and failed to agglutinate the remaining Serogroup representatives 
(Table 1) . Similar results were seen when tested by ELISA (Figure 5). In 
contrast, results obtained with different Ser ogr oups show differences when 
12 serovars of the Serogroup c anicola were evaluated by the MAT and the 
ELISA. Leptospira canicola serovars that had high agglutination titers did 
not always have the highest opt ical densities by ELISA (Table 2 & Figure 
6). Similarly, those serovar.s yei lrt i ng the highest optlcal density values 
by ELISA did not always have the lowest MAT titers . These differences may 
be inherant in methodology of the test employed . The MAT is used to obtain 
an end-point in antibody titer (15 ) . Titers of ~ 1:200 are considered to 
be non-specific (15). The MAT involves the use of viable antigens that are 
in suspension and are freely accessible to the antibody. Scoring of the 
percent agglutination is subjective, and t here is a wide lab-to-lab 
variation in MAT results (1 5 ) . In the ELISA, antigen is captured by 
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polyclonal antisera prepared against serovar canicola. Assume that a 
particular organism contains a low number of the 4D8 epitope and that the 
polyclonal antisera contains antibody against this epitope. Once the 
organism (antigen) is bound by the polyclonal antisera, potential 4D8 
binding sites are eliminated . This results in a low ELISA OD value but may 
result in a high MAT titer. Alternatively, at a 1:100 di lution, the 
polyclonal capture serum could contain high affinity antibodies specific 
for antigens of other canicola serovars and could explain the higher OD 
values with serovars yielding low MAT titers (bindjei (bindjei), and jonsis 
(jones)) . It is noteworthy that the most commonly used serovars in 
production of leptospira bacterins in the United States are serovars 
portlandvere as well as the Moulton and Hand U IV strains of serovar 
canicola. 
A total of 185 licensed leptospiral bacterins were evaluated with 
this ELISA system. All bacterins tested had an RP of ~ 1.0. Most 
bacterins passed the ELISA test when diluted 1: 20 (phase I) . Those that 
failed to pass in ~hase I, did pass when assayed without prior dilution 
(phase II). Possible explanations for these results include: a) a wide 
antigenic concentration of serovar canicola in leptospiral bacterins, b) 
interference with detection of canicola antigen by other viral and 
bacterial components, c) differences in adjuvants used in leptospiral 
bacterins, and d) the efficiency of antigen elution . The latter i s 
probably the most plausible explanation for these results. 
This ELISA-based detection system approaches the sensitivity of the 
hamster potency assay (Table 8) and indicates that the ELISA test reference 
bacterin represents an immunogenic sample. Results of the correlation 
study show that hamsters were protected with 41. 6% less organisms as 
comapred to the number of organisms required for an ELISA RP of 1.0 or 
greater. This difference is r~presented by a single 2-fold dilution. 
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Because the currently encoded potency assay is an in vivo model, if this 
experiment were repeated several times, the dilution that provided hamster 
protection may equal the dilution that would result in an RP of 1.0. 
With regard to correlation of the ELISA data with in vivo data, four 
facts must be realized: a) the hamster is not a natural reservior for 
leptospirosis, b) in addition to antibody-mediated processes, there are 
also cell-mediated processes involved in the response to Leptospira 
infection, c) the hamster potency assay required the bacterin to be diluted 
to l/80th of the host animal dose, and d) the ELISA protocol does not 
involve diluting the bacterins to l/80th of the host animal dose. For 
these reasons, any ELISA developed for measuring the realtive potency of 
bacterins will never parallel the in vivo model exactly. 
The use of this ELISA provides a reproducible alternate method for 
testing the L. canicola component of leptospira bacterins . In addition, 
this test system could be used for other purposes, such as screening of 
master seed cultures used in the manufacture of leptospiral bacterins and 
for screening cultures for cross-contamination by other L. interrogans 
serovars. This ELISA could be modified to be used for diagnostic purposes, 
such as detection of leptospires in biological samples, histopathology, 
etc. Other assays currently being developed in this laboratory to measure 
anitgen(s) of serovars grippotyphosa and icterohaemorrhagiae will provide 
additional in vitro testing methods for the evaluation of leptospiral 
bacterins and reduce even further the need for in vivo testing of these 
products. 
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GENERAL SUMMARY 
Leptospira interrogans serovars pomona and canicola are the cause of 
leptospirosis in dogs, cattle, swine, and horses. Virulence attributes of 
L. interrogans include motility , a hemolysin, proposed cytolysin 
production, and evasion of the host immune response (26-33). Vaccination 
has been shown to be an effective preventative measure (25,38,41 , 43 , 50,51). 
After an active infection, immunity is life-long and is serovar- specif ic 
( 25) • 
The current potency test for licensing leptospiral bacterins involves 
a hamster assay in which 80% uf vaccinated hamsters must survive a virulent 
challenge (1). This assay is very expensive, time consuming, and involves 
exposure of personnel to live organisms that are pathogenic for humans . 
One of the policies of the National Veterinary Services Laboratories (NVSL) 
is to reduce the use of an i mals for testing when possible. An in vitro 
assay for measuring the relative potency of leptospiral bacterins is in 
line with this policy. This thesis describes the development of in vitro 
assays for measuring the relative potency of leptospiral bacterins 
containing serovars pomona and canicola. 
Monoclonal antibodies directed against surface antigens of serovars 
L. pomona and L . canicola were developed using Triton X-100 extracts of 
these serovars. The L. pomc;;a 2D7 hybr id0m;! c l one secreted IgA-type 
antibody. The L. canicola 408 hybridoma clone secreted IgM-type antibody. 
Both MAbs were shown to be agglutinating by MAT and protective in hamsters. 
Specificity of the two MAbs was demonstrated with no cross reactivity 
between heterologous serovars. 
There are many antigenic leptospiral proteins that have been 
described. Some of the major cross-reactive antigens are part of the axial 
filaments (5,10,22 , 23 , 24). Two proteins of the axial filament with 
approximate molecular mass of 30 kDa and 40 kDa are the most evident in 
125 
SOS-PAGE electrophoresis (5-7,41,50,59). It is known that the axial 
filmanet has some immunogenic properties (9,58,31). There are several 
reports of MAbs directed against leptospiral LPS (54,55,60,61-63). Both 
the 207 (L. pomona) and 408 (L. canicola) MAbs reacted with antigens on the 
intact cell of the respectiv0 serovars. SincP. leptospi=al b acterins are 
composed of inactivated whole cells of L. interrogans serovars , these cell 
surface antigens represent an excellent parameter for relative potency 
assessment . 
The L. pomona 207 clone was shown to react with an epitope present on 
an LPS-like moiety of 14-16 kDa in the Triton X-100 extract and a single 
LPS-like moiety of 18 kDa in the whole cell preparation. There are two 
possible explanations for the difference in the sizes detected by the 207 
MAb. First, the 18 kDa moiety may represent the 14-16 kDa moiety in 
association with other surface membrane components on the intact cell. The 
extraction process may have remov ed these associated components yielding 
the 14-16 kDa antigen . Secondly, the 14-16 kDa moi~~Y may be present in a 
three-dimensional conformation that is different when inserted in the 
membrane as compared to the conformation of the extracted antigen. 
The 4DB MAb was shown to react with an epitope on three different 
moieties (i.e. bands) present in the L. canicola Triton X-100 extract and 
whole cell preparation . Based on the results of proteinase digestion and 
LPS-silver stain studies, it can only be speculated that the 408 MAb reacts 
with an epitope present on three LPS-like moieties present in Triton X-100 
extract and whole cell preparations of serovar canicola. They do not prove 
that these moieties are LPS, but they do indicate that an LPS-like 
substance is associated with the epitope recognized by the 408 MAb. This 
i s be consistent with literature that leptospiral LPS differs from 
classical LPS (5,11-15). A third explanation for the difference in sizes 
of moieties recognized by the 408 MAb may be due to post-translational 
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molecules being produced during heat-inactivation. By raising the 
temperature of the growth medium, the organisms begin synthesizing heat-
shock proteins and other molecules related to the pathogenesis of the 
organism. At 56° C proteins that may have been secreted from the cell in 
response to the initial rise in temperature, may denature (coagulate) and 
aggregate on the cell surface. 
The LPS silver stain used to stain LPS in the pomona and canicola 
preparations probably stained some protein in addition to the LPS. This is 
likely due to: a) fluctuations in room temperature, and/or b) incorrect 
concentration of ammonium hydroxide used in the color development solution. 
The oxidation of the LPS-like moieties may have been affected by changes in 
room temperature. On the other hand, if too much ammonium hydroxide was 
present, proteins may have been stained. 
The two MAbs were used to develop in vitro assays for measuring the 
relative potency of bacterins containing L. pomona (2D7) and L. canicola 
(4DB). Both in vitro assays involve coating microtitration plates with 
polyclonal rabbit antisera to capture antigen in bacterins. Antigen is 
detected by adding a specified dilution of ascites fluid containing 
monoclonal antibodies against the appropriate serovar. After incubation 
with anti-mouse horseradish peroxidase antibody conjugate, the antigen-
antibody complex is visualized with either TMB (L. pomona) or ABTS 
(L. canicola). The blank subtracted optical density (OD) values for each 
test sample are then used to culculate the relative potency using the NVSL 
RelPot program (version 3.0) . 
Differences were encountered in regard to treatment of the bacterin 
prior to use in the ELISA protocols. As opposed to the 2D7 MAb, the 4DB 
MAb bound to aluminum hydroxide adjuvant. When a commercial 2% aluminum 
hydroxide gel solution was diluted to correspond to the final concentration 
in an accompanying treated bacterin, the 4DB MAb was shown to be bound to 
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the gel. This may be due to the chemical nature of the IgM-type antibody 
as compared to the IgA-type antibody. An IgM is pentameric and contains 
more disulfide bonds and carbohydrate groups in the hinge region than does 
an IgA molecule. Because of possible differences in the avidity of these 
two MAbs, the L. canicola ELISA protocol required that bacterins adjuvanted 
with aluminum hydroxide be treated to elute the antigen from the adjuvant 
prior to evaluation in the ELISA . Although the 408 MAb did not bind to an 
oil preparation, the oil appeared to hinder detection of all epitopes 
present in the bacterin. For this reason, those bacterins containing oil 
as the sole adjuvant required treatment to elute the a ntigen. There were 
several bacterins that contained a combination of adjuvants as well as some 
products that contained adjuvants that did not interfere with the detection 
of the antigen. 
All products evaluated by either ELISA assay met the minimum relative 
potency requirement of 1.0 or greater . The presence of adjuvants in 
bacterins does not appear to hinder detection of epitopes by the pomona 207 
MAb. Although the canicola 408 MAb did not bind to an oil preparation, the 
oil appeared to hinder detPction of all epitopes presen~ in the bacterin . 
For this reason, those bacterins containing oil as an adjuvant require 
treatment to elute the antigen . 
Both ELISA's approximated the sensitivity of the hamster 
potency assay for the respective serovars. Whenever developing an in vitro 
assay as an alternative to an in vivo model, it is important to realize 
that several obstacles must be o vercome. These ELISA'S measure a single 
protective immunogen (epitope) that is present in multiple copies on the 
surface of the organism. It would be naive to think that this one 
immunogen (epitope) is the only one of importance. On the contrary, one 
must think of more than one immunogen that is involved in the host immune 
response to infection. This is particularly true with b~cterial 
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infections. Another obstacle to developing the "perfect" ELISA system is 
the extreme intercellular in~erplay involved in re~pons~ to most 
infections. Most infections involve both arms of the immune system and 
include the cellular responses to a wide variety of cytokines. These 
interactions cannot be reproduced in an ELISA-based detection system. 
Another important variable to be considered is the adjuvant(s) that is used 
as an immunostimulant. Some of these not only affect humeral responses, 
but also cell-mediated responses. For some of these adjuvants, antigen may 
be adequately eluted. For others, there is no known method of eluting the 
antigen. For those products containing combinations of adjuvants , the 
problem is compounded by the fact that either a) the adjuvants may 
interfere with each other, or b) antigen may not be able to be eluted 
efficiently for ap~lication to an ELISA system. There is also the 
potential for new adjuvants to be developed that require less antigenic 
mass to produce protective immunity. In this case , these ELISA assays 
would have to be modified to reflect these adjuvants. In addition, the 
physiological state of the host must be considered when evaluating 
correlation data. Is the anima l immunosuppressed (i.e., viral infection, 
genetically pre-disposed to suppression , currently unde r steroid therapy , 
stress, malnutrition, etc)? What is the hormonal state of the animal 
(i.e., estrus , pregnancy, parity, etc)? Given the various environmental 
and genetic interactions related to immune function, to expect exact 
parallelism with in vivo data wou ld be ludicrous . 
The development of alternate methods for t es ting of veterinary 
biologicals is a great advance over in vivo assays . In vitro assays are 
safer , more precise, and quicke r to perform as compared to in vivo assays 
in laboratory animal models. However, the correlation of in vitro data 
with in vivo data is not always exact. The mu ltitude of cellular 
interactions and the presence o f cytokines that are present with infectious 
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diseases in the intact animal is an obstacle which may never be overcome 
with an in vitro test system . In addition, there is the lack of assessment 
of the effect of the presence of adjuvants in most leptospiral bacterins. 
The more immunostimulatory adjuvant will require l ess antigen to be present 
in the product to elicit an a dequate protective humeral response. Since no 
elution treatment will ever release 100% o f the bound antigen, this is a 
variance that may require more attention. This thesis describes the 
development of an alternative method for measuring potency of leptospiral 
bacterins containing serovars pomona and canicola . Work is planned for 
developing similar assays for serovars icterohaemorrhagiae, grippotyphosa, 
bratislava, and hardjo . 
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